TAN PS的个人主页 - 老虎社区

TAN PS

TAN PS

暂无个人介绍

IP属地：未知

61关注

3粉丝

1主题

0勋章

2022-01-21

OK👌

3 COVID Stocks That Will Make Billions in 2022

2022-01-21

OK👌

Stocks rise as Wall Street shakes off red hot inflation report

2022-01-19

Ok👌

外媒头条：一次加息50个基点！市场预期越发激进

2021-12-28

Ok,goood

2021-12-27

Ok, great idea

2021-12-27

Okokok☺️☺️☺️

2021-12-26

Ok

抱歉，原内容已删除

2021-12-25

Ok

抱歉，原内容已删除

2021-12-24

Okokok good idea

2021-12-24

Ok

抱歉，原内容已删除

2021-12-20

Ok

Netflix Stock: Here's How India Can Impact Its Future Earnings

2021-12-20

Ok

Why inflation and the U.S. policy response will be key for markets in 2022

2021-12-18

Noted

抱歉，原内容已删除

2021-12-17

Notes

Oracle in talks to buy Cerner

2021-12-17

Ok, noted

抱歉，原内容已删除

2021-12-16

☺️

抱歉，原内容已删除

2021-12-16

✌️✌️✌️

抱歉，原内容已删除

2021-12-15

🤔🤔🤔

抱歉，原内容已删除

2021-12-14

🤔🤔🤔

Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion

2021-12-09

😲😲😲

'Proceed with caution': here's what Wall Street analysts see for the U.S. stock market in 2022

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3582126034262927","uuid":"3582126034262927","gmtCreate":1619032504746,"gmtModify":1642212623813,"name":"TAN PS","pinyin":"tanpstanps","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":61,"tweetSize":20,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":630345015,"gmtCreate":1642725433815,"gmtModify":1642725441780,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"OK👌","listText":"OK👌","text":"OK👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/630345015","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","kind":"news","pubTimestamp":1641612579,"share":"https://www.laohu8.com/m/news/1134509683?lang=&edition=full","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<html><head></head><body><p>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>A safe harbor in stormy weather</b></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><b>The antibody market all to itself</b></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc.","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1056,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":630342483,"gmtCreate":1642725393521,"gmtModify":1642725393632,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"OK👌","listText":"OK👌","text":"OK👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/630342483","repostId":"1138592368","repostType":4,"repost":{"id":"1138592368","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641997842,"share":"https://www.laohu8.com/m/news/1138592368?lang=&edition=full","pubTime":"2022-01-12 22:30","market":"us","language":"en","title":"Stocks rise as Wall Street shakes off red hot inflation report","url":"https://stock-news.laohu8.com/highlight/detail?id=1138592368","media":"Tiger Newspress","summary":"Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high","content":"<html><head></head><body><p>Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high rate of price increases across the recovering economy. Still, this came a day following remarks from Federal Reserve Chair Jerome Powell reasserting that the central bank would step in as needed to rein in rising prices.</p><p>The Bureau of Labor Statistics&#39; December Consumer Price Index (CPI)showed prices rose at a 7.0% year-over-year rate at the end of 2021, marking the fastest increase since 1982. This matched consensus estimates, based on Bloomberg data, and accelerated from November&#39;s already elevated 6.8% increase. On a month-over-month basis, consumer prices rose 0.5%, or slightly more than the 0.4% rise expected, to mark an eighteenth consecutive month of prices increases.</p><p>Excluding food and energy prices, the so-called core measure of consumer prices rose 5.5% in December over last year, coming in at the fastest rate since 1991.</p><p>Wednesday&#39;s market moves came following a rebound rally on Tuesday, with markets at least temporarily finding relief in assurances from Federal Reserve Chair Jerome Powell that the central bank would step in as necessary to ease rising prices. InPowell&#39;s renomination hearing before the Senate Banking Committee, the central bank leader reiterated that the Fed would use its policy tools to bring down inflation.</p><p>“If we see inflation persisting at high levels, longer than expected, if we have to raise interest rates more over time, then we will,” Powell said during the hearing.</p><p>The central bankpreviously telegraphed it was eyeing three interest rate hikesthis year to bring benchmark rates up from their current near-zero levels. However, some topWall Street firms have predictedthe Fed will raise rates four times given the current inflationary backdrop.</p><p>But though Powell doubled down on the Fed&#39;s goal of curbing inflation and using interest rate hikes as a tool to achieve this, he revealed little further about the Fed&#39;s plan to begin shrinking its nearly $9 trillion balance sheet. The Fed&#39;s December meeting minutes last week suggested central bank officials were beginning to discuss drawing down the Fed&#39;s balance sheet after nearly two years of asset purchases to help support markets during the pandemic. Powell did reiterate in his hearing he expected the balance sheet runoff process would begin this year.</p><p>&#34;I think the biggest comment on most investors&#39; minds that we talk to around the world would be a &#39;policy mistake&#39; that the Fed might be too aggressive,&#34; Brian Belski, BMO Capital Markets chief investment strategist,told Yahoo Finance Live on Tuesday.&#34;Mr. Powell basically came out today and said this is going to be a process ... with respect to how long this is going to take, and I think that&#39;s what&#39;s calming investors.&#34;</p><p>Though prospects of higher borrowing costs and tighter financial conditions have stirred up volatility in U.S. equities and tech stocks especially in recent sessions, Tuesday&#39;s session saw a reversal, with the tech-heavy Nasdaq Composite sharply outperforming.</p><p>&#34;The issue with tech, I would argue, is not so much one of a little extra duration exposure because growth is further away, but it&#39;s simply one of valuation,&#34; Simeon Hyman, ProShares Global Investment Strategist,told Yahoo Finance Live on Tuesday.&#34;And indeed those top-heavy, largest-cap tech stocks perhaps just were a little bit expensive going into the end of last year and the beginning of 2022. But don&#39;t completely rule out good growth stories because that is the biggest defense against inflation. It is the growth of earnings and dividends.&#34;</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks rise as Wall Street shakes off red hot inflation report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks rise as Wall Street shakes off red hot inflation report\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-12 22:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high rate of price increases across the recovering economy. Still, this came a day following remarks from Federal Reserve Chair Jerome Powell reasserting that the central bank would step in as needed to rein in rising prices.</p><p>The Bureau of Labor Statistics&#39; December Consumer Price Index (CPI)showed prices rose at a 7.0% year-over-year rate at the end of 2021, marking the fastest increase since 1982. This matched consensus estimates, based on Bloomberg data, and accelerated from November&#39;s already elevated 6.8% increase. On a month-over-month basis, consumer prices rose 0.5%, or slightly more than the 0.4% rise expected, to mark an eighteenth consecutive month of prices increases.</p><p>Excluding food and energy prices, the so-called core measure of consumer prices rose 5.5% in December over last year, coming in at the fastest rate since 1991.</p><p>Wednesday&#39;s market moves came following a rebound rally on Tuesday, with markets at least temporarily finding relief in assurances from Federal Reserve Chair Jerome Powell that the central bank would step in as necessary to ease rising prices. InPowell&#39;s renomination hearing before the Senate Banking Committee, the central bank leader reiterated that the Fed would use its policy tools to bring down inflation.</p><p>“If we see inflation persisting at high levels, longer than expected, if we have to raise interest rates more over time, then we will,” Powell said during the hearing.</p><p>The central bankpreviously telegraphed it was eyeing three interest rate hikesthis year to bring benchmark rates up from their current near-zero levels. However, some topWall Street firms have predictedthe Fed will raise rates four times given the current inflationary backdrop.</p><p>But though Powell doubled down on the Fed&#39;s goal of curbing inflation and using interest rate hikes as a tool to achieve this, he revealed little further about the Fed&#39;s plan to begin shrinking its nearly $9 trillion balance sheet. The Fed&#39;s December meeting minutes last week suggested central bank officials were beginning to discuss drawing down the Fed&#39;s balance sheet after nearly two years of asset purchases to help support markets during the pandemic. Powell did reiterate in his hearing he expected the balance sheet runoff process would begin this year.</p><p>&#34;I think the biggest comment on most investors&#39; minds that we talk to around the world would be a &#39;policy mistake&#39; that the Fed might be too aggressive,&#34; Brian Belski, BMO Capital Markets chief investment strategist,told Yahoo Finance Live on Tuesday.&#34;Mr. Powell basically came out today and said this is going to be a process ... with respect to how long this is going to take, and I think that&#39;s what&#39;s calming investors.&#34;</p><p>Though prospects of higher borrowing costs and tighter financial conditions have stirred up volatility in U.S. equities and tech stocks especially in recent sessions, Tuesday&#39;s session saw a reversal, with the tech-heavy Nasdaq Composite sharply outperforming.</p><p>&#34;The issue with tech, I would argue, is not so much one of a little extra duration exposure because growth is further away, but it&#39;s simply one of valuation,&#34; Simeon Hyman, ProShares Global Investment Strategist,told Yahoo Finance Live on Tuesday.&#34;And indeed those top-heavy, largest-cap tech stocks perhaps just were a little bit expensive going into the end of last year and the beginning of 2022. But don&#39;t completely rule out good growth stories because that is the biggest defense against inflation. It is the growth of earnings and dividends.&#34;</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138592368","content_text":"Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high rate of price increases across the recovering economy. Still, this came a day following remarks from Federal Reserve Chair Jerome Powell reasserting that the central bank would step in as needed to rein in rising prices.The Bureau of Labor Statistics' December Consumer Price Index (CPI)showed prices rose at a 7.0% year-over-year rate at the end of 2021, marking the fastest increase since 1982. This matched consensus estimates, based on Bloomberg data, and accelerated from November's already elevated 6.8% increase. On a month-over-month basis, consumer prices rose 0.5%, or slightly more than the 0.4% rise expected, to mark an eighteenth consecutive month of prices increases.Excluding food and energy prices, the so-called core measure of consumer prices rose 5.5% in December over last year, coming in at the fastest rate since 1991.Wednesday's market moves came following a rebound rally on Tuesday, with markets at least temporarily finding relief in assurances from Federal Reserve Chair Jerome Powell that the central bank would step in as necessary to ease rising prices. InPowell's renomination hearing before the Senate Banking Committee, the central bank leader reiterated that the Fed would use its policy tools to bring down inflation.“If we see inflation persisting at high levels, longer than expected, if we have to raise interest rates more over time, then we will,” Powell said during the hearing.The central bankpreviously telegraphed it was eyeing three interest rate hikesthis year to bring benchmark rates up from their current near-zero levels. However, some topWall Street firms have predictedthe Fed will raise rates four times given the current inflationary backdrop.But though Powell doubled down on the Fed's goal of curbing inflation and using interest rate hikes as a tool to achieve this, he revealed little further about the Fed's plan to begin shrinking its nearly $9 trillion balance sheet. The Fed's December meeting minutes last week suggested central bank officials were beginning to discuss drawing down the Fed's balance sheet after nearly two years of asset purchases to help support markets during the pandemic. Powell did reiterate in his hearing he expected the balance sheet runoff process would begin this year.\"I think the biggest comment on most investors' minds that we talk to around the world would be a 'policy mistake' that the Fed might be too aggressive,\" Brian Belski, BMO Capital Markets chief investment strategist,told Yahoo Finance Live on Tuesday.\"Mr. Powell basically came out today and said this is going to be a process ... with respect to how long this is going to take, and I think that's what's calming investors.\"Though prospects of higher borrowing costs and tighter financial conditions have stirred up volatility in U.S. equities and tech stocks especially in recent sessions, Tuesday's session saw a reversal, with the tech-heavy Nasdaq Composite sharply outperforming.\"The issue with tech, I would argue, is not so much one of a little extra duration exposure because growth is further away, but it's simply one of valuation,\" Simeon Hyman, ProShares Global Investment Strategist,told Yahoo Finance Live on Tuesday.\"And indeed those top-heavy, largest-cap tech stocks perhaps just were a little bit expensive going into the end of last year and the beginning of 2022. But don't completely rule out good growth stories because that is the biggest defense against inflation. It is the growth of earnings and dividends.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":1022,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697404839,"gmtCreate":1642551869823,"gmtModify":1642551870152,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"Ok👌","listText":"Ok👌","text":"Ok👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697404839","repostId":"2204841800","repostType":2,"repost":{"id":"2204841800","kind":"news","pubTimestamp":1642541820,"share":"https://www.laohu8.com/m/news/2204841800?lang=&edition=full","pubTime":"2022-01-19 05:37","market":"us","language":"zh","title":"外媒头条：一次加息50个基点！市场预期越发激进","url":"https://stock-news.laohu8.com/highlight/detail?id=2204841800","media":"新浪财经","summary":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：1、货币市场预计美联储或一次升息50基点 将是2020年以来最大动作2、微软发起其史上最大规模收购 以近690亿美元收购动视暴雪3、贝莱德CEO：美联储“","content":"<html><head></head><body><p><b>全球财经媒体昨夜今晨共同关注的头条新闻主要有：</b></p><blockquote><b>1、货币市场预计美联储或一次升息50基点 将是2020年以来最大动作</b></blockquote><blockquote><b>2、<a href=\"https://laohu8.com/S/MSFT\">微软</a>发起其史上最大规模收购 以近690亿美元收购<a href=\"https://laohu8.com/S/ATVI\">动视暴雪</a></b></blockquote><blockquote><b>3、<a href=\"https://laohu8.com/S/BLK\">贝莱德</a>CEO：美联储“激进”立场或导致收益率曲线趋平</b></blockquote><blockquote><b>4、原油飙升至2014年以来高点 拜登政府称正继续与产油国合作</b></blockquote><blockquote><b>5、研究显示omicron感染浪潮可能降低疫情未来的严重程度</b></blockquote><blockquote><b>6、2021年<a href=\"https://laohu8.com/S/AAPL\">苹果</a>手机占全球智能手机出货量22% 位居第一</b></blockquote><p><img src=\"https://static.tigerbbs.com/698315ff48290ccd4244f61fe7019f2b\" tg-width=\"550\" tg-height=\"369\" referrerpolicy=\"no-referrer\"/></p><p><b>货币市场预计美联储或一次升息50基点 将是2020年以来最大动作</b></p><p>货币市场价格显示，越来越多投资者预期美联储可能逾二十年来首次大规模提高借贷成本。</p><p>虽然加息25个基点仍是最有可能的情形，但掉期市场现在预计3月底前加息幅度将超过25个基点。鉴于本月政策会议预计不会有任何行动，这表明交易员至少正在考虑3月加息50个基点的可能性。自2000年5月以来， 美联储还从没有一口气加息这么多过。</p><p>近日来围绕美联储更大幅加息的猜测升温可能加剧了周二美国国债跌势。 <a href=\"https://laohu8.com/S/JPM\">摩根大通</a>首席执行官杰米·戴蒙上周警告美联储收紧政策可能不会像一些人预期的那样“和风细雨”，亿万富翁投资者Bill Ackman表示美联储应该在3月加息50个基点，以重建公信力。</p><p>CFTC最新持仓数据显示，对冲基金将净欧洲美元空头头寸提高至2018年12月以来最大水平，投机者对10年期国债期货的看空程度也达到2020年2月以来最高。</p><p><img src=\"https://static.tigerbbs.com/d7cad28562d81d8fed2fe8d732aa7112\" tg-width=\"550\" tg-height=\"296\" referrerpolicy=\"no-referrer\"/></p><p><b><a href=\"https://laohu8.com/S/MSFT\">微软</a>发起其史上最大规模收购 以近690亿美元收购<a href=\"https://laohu8.com/S/ATVI\">动视暴雪</a></b></p><p>微软宣布以687亿美元收购动视暴雪，促成视频游戏领域的两大巨头强强联合。</p><p>作为微软有史以来进行的最大一笔收购，该交易对这家美国最大游戏发行商之一的收购价为每股95美元现金。微软称，动视暴雪首席执行官Bobby Kotick将继续担任当前职位。交易完成后，动视暴雪业务将汇报给微软游戏部门负责人Phil Spencer。</p><p>交易完成后，微软将成为按营收计算的全球第三大游戏公司，仅次于<a href=\"https://laohu8.com/S/00700\">腾讯</a>和<a href=\"https://laohu8.com/S/SNE\">索尼</a>。</p><p>将动视暴雪热门游戏收入囊中，将有助于微软扩大其Xbox游戏机内容，提高对<a href=\"https://laohu8.com/S/SONY\">索尼</a>PlayStation的竞争力。动视暴雪与Xbox的合作由来已久。这家发行商最大一款游戏《使命召唤》的成功，很大程度上是得益于微软创新性的在线平台Xbox Live，该平台允许玩家联机进行多人对战。动视暴雪大多数游戏都在Xbox游戏机上发布。</p><p><img src=\"https://static.tigerbbs.com/733e77ab67cbbd3d5818c24cbcb9916a\" tg-width=\"550\" tg-height=\"366\" referrerpolicy=\"no-referrer\"/></p><p><b><a href=\"https://laohu8.com/S/BLK\">贝莱德</a>CEO：美联储“激进”立场或导致收益率曲线趋平</b></p><p>全球最大资产管理公司贝莱德CEO Larry Fink表示，美联储快速调整货币政策以遏制通胀可能会导致美国国债收益率曲线趋于平缓。</p><p>“我认为收益率曲线将会变平，如果美联储非常激进，我甚至可以看到一条负的收益率曲线，”Fink周二表示。</p><p>收益率曲线的形状揭示了投资者对美国经济增长和货币政策的预期。美联储计划早于预期加息的鹰派立场推高了短期利率，使曲线变平。</p><p>分析师通常认为，短期美国国债收益率与较长期美债收益率之差缩小（即收益率曲线趋平），是对经济增长和货币政策不确定性的担忧迹象。负的收益率曲线或曲线倒挂通常预示着经济衰退。</p><p>“收益率曲线的形状将成为决定经济的关键问题，”Fink说。</p><p><img src=\"https://static.tigerbbs.com/894b2f0869773330f31bbaf4cb56d3ec\" tg-width=\"550\" tg-height=\"365\" referrerpolicy=\"no-referrer\"/></p><p><b>原油飙升至2014年以来高点 拜登政府称正继续与产油国合作</b></p><p>油价升至七年高点之际，白宫称拜登政府正在与产油国合作，将确保供应达到足以满足需求的水平。</p><p>美国国家安全委员会发言人Emily Horne周二在一份声明中表示，白宫计划继续在全球经济增长的背景下监控能源价格，必要时会与OPEC+国家举行磋商。</p><p>Horne称，“我们会继续与产油国和消费国合作，这些措施已经对价格产生了实际影响，我们仍然保留可解决能源价格问题的工具” 。</p><p>汽油价格上涨一直是导致拜登任期内通胀飙升的主要因素，白宫千方百计降低汽油成本。油价上涨正在损害拜登的支持率，民主党在11月中期选举中保住两院多数党地位的难度加大。</p><p><img src=\"https://static.tigerbbs.com/504a7eb8073637bdb53e621b0dd905d0\" tg-width=\"550\" tg-height=\"343\" referrerpolicy=\"no-referrer\"/></p><p><b>研究显示omicron感染浪潮可能降低疫情未来的严重程度</b></p><p>南非的研究人员表示，虽然omicron变种病毒引发一轮强烈的新冠疫情浪潮，但却可能会加速大流行病所造成各种干扰的终结，因为感染omicron的症状似乎较轻，并能提供针对德尔塔变种病毒的保护。</p><p>南非一个实验室将去年11月和12月感染omicron的23人作为样本进行的研究显示，虽然先前感染了德尔塔毒株的人可以感染omicron，但感染omicron株的人不会再感染德尔塔。</p><p>尽管omicron的感染力明显高于德尔塔，但包括南非在内的一些国家的医院和死亡率数据似乎表明，它导致的疾病严重程度较低。南非是最早出现omicron感染浪潮的国家。南非卫生研究所Alex Sigal等人的这项研究显示，omicron可以取代德尔塔毒株。</p><p>“这种取代的影响将取决于omicron的致病性是否确实低于德尔塔，”研究人员说。 “如果的确如此，那么Covid-19重症的发生率将降低，疫情对个人和社会的破坏性将会减弱。”</p><p><img src=\"https://static.tigerbbs.com/a45e0699fa17a3da9ad6e88c61dcc813\" tg-width=\"630\" tg-height=\"448\" referrerpolicy=\"no-referrer\"/></p><p><b>2021年<a href=\"https://laohu8.com/S/AAPL\">苹果</a>手机占全球智能手机出货量22% 位居第一</b></p><p>数据研究机构Canalys发布的最新报告显示，得益于iPhone 13的成功，苹果手机在2021年占全球智能手机出货量的22%，坐上全球智能手机市场的头把交椅，<a href=\"https://laohu8.com/S/SMSN.UK\">三星</a>以20%的市场份额紧随其后。此外，小米以12%排名第三，OPPO以9%排名第四，vivo以8%排名前五。</p><p>报告显示，截至2021年底，苹果手机占全球智能手机出货量的22%。Canalys指出，苹果上一次在智能手机市场排名第一是在2020年第四季度。</p><p>Canalys分析师Sanyam Chaurasia在一份声明中表示：“苹果iPhone新旗舰机在中国市场表现十分强劲。”“苹果的供应链开始复苏，但由于关键零部件短缺，苹果在第四季度仍被迫减产，无法生产足够的iPhone来满足需求。”</p></body></html>","source":"XLCJ","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>外媒头条：一次加息50个基点！市场预期越发激进</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n外媒头条：一次加息50个基点！市场预期越发激进\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-19 05:37 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2022-01-19/doc-ikyamrmz6036284.shtml><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>全球财经媒体昨夜今晨共同关注的头条新闻主要有：1、货币市场预计美联储或一次升息50基点 将是2020年以来最大动作2、微软发起其史上最大规模收购 以近690亿美元收购动视暴雪3、贝莱德CEO：美联储“激进”立场或导致收益率曲线趋平4、原油飙升至2014年以来高点 拜登政府称正继续与产油国合作5、研究显示omicron感染浪潮可能降低疫情未来的严重程度6、2021年苹果手机占全球智能手机出货量22%...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2022-01-19/doc-ikyamrmz6036284.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/02a85629f2a809e4eabd8677140a5f70","relate_stocks":{".IXIC":"NASDAQ Composite","BK4550":"红杉资本持仓",".DJI":"道琼斯","BK4504":"桥水持仓",".SPX":"S&P 500 Index","BK4534":"瑞士信贷持仓","BK4559":"巴菲特持仓"},"source_url":"https://finance.sina.com.cn/stock/usstock/c/2022-01-19/doc-ikyamrmz6036284.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2204841800","content_text":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：1、货币市场预计美联储或一次升息50基点 将是2020年以来最大动作2、微软发起其史上最大规模收购 以近690亿美元收购动视暴雪3、贝莱德CEO：美联储“激进”立场或导致收益率曲线趋平4、原油飙升至2014年以来高点 拜登政府称正继续与产油国合作5、研究显示omicron感染浪潮可能降低疫情未来的严重程度6、2021年苹果手机占全球智能手机出货量22% 位居第一货币市场预计美联储或一次升息50基点 将是2020年以来最大动作货币市场价格显示，越来越多投资者预期美联储可能逾二十年来首次大规模提高借贷成本。虽然加息25个基点仍是最有可能的情形，但掉期市场现在预计3月底前加息幅度将超过25个基点。鉴于本月政策会议预计不会有任何行动，这表明交易员至少正在考虑3月加息50个基点的可能性。自2000年5月以来， 美联储还从没有一口气加息这么多过。近日来围绕美联储更大幅加息的猜测升温可能加剧了周二美国国债跌势。 摩根大通首席执行官杰米·戴蒙上周警告美联储收紧政策可能不会像一些人预期的那样“和风细雨”，亿万富翁投资者Bill Ackman表示美联储应该在3月加息50个基点，以重建公信力。CFTC最新持仓数据显示，对冲基金将净欧洲美元空头头寸提高至2018年12月以来最大水平，投机者对10年期国债期货的看空程度也达到2020年2月以来最高。微软发起其史上最大规模收购 以近690亿美元收购动视暴雪微软宣布以687亿美元收购动视暴雪，促成视频游戏领域的两大巨头强强联合。作为微软有史以来进行的最大一笔收购，该交易对这家美国最大游戏发行商之一的收购价为每股95美元现金。微软称，动视暴雪首席执行官Bobby Kotick将继续担任当前职位。交易完成后，动视暴雪业务将汇报给微软游戏部门负责人Phil Spencer。交易完成后，微软将成为按营收计算的全球第三大游戏公司，仅次于腾讯和索尼。将动视暴雪热门游戏收入囊中，将有助于微软扩大其Xbox游戏机内容，提高对索尼PlayStation的竞争力。动视暴雪与Xbox的合作由来已久。这家发行商最大一款游戏《使命召唤》的成功，很大程度上是得益于微软创新性的在线平台Xbox Live，该平台允许玩家联机进行多人对战。动视暴雪大多数游戏都在Xbox游戏机上发布。贝莱德CEO：美联储“激进”立场或导致收益率曲线趋平全球最大资产管理公司贝莱德CEO Larry Fink表示，美联储快速调整货币政策以遏制通胀可能会导致美国国债收益率曲线趋于平缓。“我认为收益率曲线将会变平，如果美联储非常激进，我甚至可以看到一条负的收益率曲线，”Fink周二表示。收益率曲线的形状揭示了投资者对美国经济增长和货币政策的预期。美联储计划早于预期加息的鹰派立场推高了短期利率，使曲线变平。分析师通常认为，短期美国国债收益率与较长期美债收益率之差缩小（即收益率曲线趋平），是对经济增长和货币政策不确定性的担忧迹象。负的收益率曲线或曲线倒挂通常预示着经济衰退。“收益率曲线的形状将成为决定经济的关键问题，”Fink说。原油飙升至2014年以来高点 拜登政府称正继续与产油国合作油价升至七年高点之际，白宫称拜登政府正在与产油国合作，将确保供应达到足以满足需求的水平。美国国家安全委员会发言人Emily Horne周二在一份声明中表示，白宫计划继续在全球经济增长的背景下监控能源价格，必要时会与OPEC+国家举行磋商。Horne称，“我们会继续与产油国和消费国合作，这些措施已经对价格产生了实际影响，我们仍然保留可解决能源价格问题的工具” 。汽油价格上涨一直是导致拜登任期内通胀飙升的主要因素，白宫千方百计降低汽油成本。油价上涨正在损害拜登的支持率，民主党在11月中期选举中保住两院多数党地位的难度加大。研究显示omicron感染浪潮可能降低疫情未来的严重程度南非的研究人员表示，虽然omicron变种病毒引发一轮强烈的新冠疫情浪潮，但却可能会加速大流行病所造成各种干扰的终结，因为感染omicron的症状似乎较轻，并能提供针对德尔塔变种病毒的保护。南非一个实验室将去年11月和12月感染omicron的23人作为样本进行的研究显示，虽然先前感染了德尔塔毒株的人可以感染omicron，但感染omicron株的人不会再感染德尔塔。尽管omicron的感染力明显高于德尔塔，但包括南非在内的一些国家的医院和死亡率数据似乎表明，它导致的疾病严重程度较低。南非是最早出现omicron感染浪潮的国家。南非卫生研究所Alex Sigal等人的这项研究显示，omicron可以取代德尔塔毒株。“这种取代的影响将取决于omicron的致病性是否确实低于德尔塔，”研究人员说。 “如果的确如此，那么Covid-19重症的发生率将降低，疫情对个人和社会的破坏性将会减弱。”2021年苹果手机占全球智能手机出货量22% 位居第一数据研究机构Canalys发布的最新报告显示，得益于iPhone 13的成功，苹果手机在2021年占全球智能手机出货量的22%，坐上全球智能手机市场的头把交椅，三星以20%的市场份额紧随其后。此外，小米以12%排名第三，OPPO以9%排名第四，vivo以8%排名前五。报告显示，截至2021年底，苹果手机占全球智能手机出货量的22%。Canalys指出，苹果上一次在智能手机市场排名第一是在2020年第四季度。Canalys分析师Sanyam Chaurasia在一份声明中表示：“苹果iPhone新旗舰机在中国市场表现十分强劲。”“苹果的供应链开始复苏，但由于关键零部件短缺，苹果在第四季度仍被迫减产，无法生产足够的iPhone来满足需求。”","news_type":1},"isVote":1,"tweetType":1,"viewCount":1822,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696638036,"gmtCreate":1640677949442,"gmtModify":1640677949520,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"Ok,goood","listText":"Ok,goood","text":"Ok,goood","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696638036","isVote":1,"tweetType":1,"viewCount":1402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696076550,"gmtCreate":1640587154486,"gmtModify":1640587154568,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"Ok, great idea","listText":"Ok, great idea","text":"Ok, great idea","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696076550","isVote":1,"tweetType":1,"viewCount":973,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698712448,"gmtCreate":1640541251767,"gmtModify":1640541251767,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"Okokok☺️☺️☺️","listText":"Okokok☺️☺️☺️","text":"Okokok☺️☺️☺️","images":[{"img":"https://static.tigerbbs.com/a253a16a74a2b4e30af15fc0fad7fd1b","width":"1599","height":"899"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698712448","isVote":1,"tweetType":1,"viewCount":1264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":698424747,"gmtCreate":1640503796905,"gmtModify":1640503796987,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698424747","repostId":"2193781141","repostType":4,"isVote":1,"tweetType":1,"viewCount":1497,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698214842,"gmtCreate":1640404859740,"gmtModify":1640404859857,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698214842","repostId":"2193720178","repostType":2,"isVote":1,"tweetType":1,"viewCount":1797,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698820820,"gmtCreate":1640343733999,"gmtModify":1640344031317,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"Okokok good idea","listText":"Okokok good idea","text":"Okokok good idea","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698820820","isVote":1,"tweetType":1,"viewCount":1107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698867692,"gmtCreate":1640343626830,"gmtModify":1640343654207,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698867692","repostId":"2193414198","repostType":2,"isVote":1,"tweetType":1,"viewCount":1215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693386387,"gmtCreate":1639971218175,"gmtModify":1639971218241,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693386387","repostId":"1155306648","repostType":4,"repost":{"id":"1155306648","kind":"news","pubTimestamp":1639969754,"share":"https://www.laohu8.com/m/news/1155306648?lang=&edition=full","pubTime":"2021-12-20 11:09","market":"us","language":"en","title":"Netflix Stock: Here's How India Can Impact Its Future Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1155306648","media":"TheStreet","summary":"The quest for more subscribers in the Streaming Wars has caused Netflix to lower its prices in India","content":"<p>The quest for more subscribers in the Streaming Wars has caused Netflix to lower its prices in India. But here's why this could be a good sign.</p>\n<p>In the ongoing Streaming Wars, rival video giants have had to adopt different strategies in order to stay ahead of the competition.</p>\n<p>That's certainly been the case with Netflix. This week, the company decided to cut subscription prices in India.</p>\n<p>While the South Asian country isn't Netflix's main target market, its performance there could be an important factor in predicting NFLX stock's future growth.</p>\n<p>Let's explore why.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/15d8cde6e2a4cc861d11e836c35818ca\" tg-width=\"1240\" tg-height=\"827\" referrerpolicy=\"no-referrer\"><span>Figure 1: Netflix content focused on Indian audiences.</span></p>\n<p><b>What Did Netflix Do?</b></p>\n<p>Netflix slashed its subscription prices in India by 60% in a bid to stay ahead of its main competitors in that country -- namely, Disney&nbsp;and Amazon. For years, Netflix had been more expensive than its rivals in India.</p>\n<p>Netflix is hoping that its price cut will capture a larger market and ensure its dominance in the South Asian country.</p>\n<p>Here's a comparison of the current prices for streaming services in India:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e42c207b1e5bc4ed5fcc8bb953a04a36\" tg-width=\"400\" tg-height=\"186\" referrerpolicy=\"no-referrer\"><span>Figure 2: Streaming platforms prices on India.</span></p>\n<p>(US $ 1 = 75,8600 rupees)</p>\n<p>Netflix previously cost 499,000 rupees (roughly $6.60).</p>\n<p>Why Did Netflix Cut Prices in India?</p>\n<p>India is the second most populous country in the world. Currently, around 1.4 billion people live there.</p>\n<p>However, not all of them have internet -- and, therefore, Netflix -- access.</p>\n<p>According to Statista, internet penetration in India is only 50%. However, that percentage is growing, motivating Netflix to invest in content streaming in the country.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/653307f7e4b643f7698a0954a7c109f5\" tg-width=\"847\" tg-height=\"409\" referrerpolicy=\"no-referrer\"><span>Figure 3: Internet penetration rate percentage in India.</span></p>\n<p><b>Market Share: The Most Important Metric</b></p>\n<p>Netflix doesn't have the huge market share in India that it does in the U.S.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8b3ab6c4b8090983c2f9da4e95a9317a\" tg-width=\"552\" tg-height=\"286\" referrerpolicy=\"no-referrer\"><span>Figure 4: India video streaming market share (Q2 2021).</span></p>\n<p>So the company has been forced to try some aggressive strategies, such as lowering its subscription prices.</p>\n<p>Even if the lower prices result in profit loss, they could translate to a larger customer base in the massive Asian country. As more people come online in India, they have the potential to become an important source of revenue for the company.</p>\n<p><b>Our Take</b></p>\n<p>In most cases, investors don't view price cuts as good moves. After all, they mean lower returns.</p>\n<p>However, in the case of companies that are still growing and gradually increasing their market share, it can be a good strategy.</p>\n<p>Looking specifically at Netflix, we think this could translate to long-term gains for the stock with little impact on NFLX in the short term.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Netflix Stock: Here's How India Can Impact Its Future Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNetflix Stock: Here's How India Can Impact Its Future Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 11:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/streaming/nflx/netflix-stock-heres-how-india-can-impact-its-future-earnings><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The quest for more subscribers in the Streaming Wars has caused Netflix to lower its prices in India. But here's why this could be a good sign.\nIn the ongoing Streaming Wars, rival video giants have ...</p>\n\n<a href=\"https://www.thestreet.com/streaming/nflx/netflix-stock-heres-how-india-can-impact-its-future-earnings\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NFLX":"奈飞"},"source_url":"https://www.thestreet.com/streaming/nflx/netflix-stock-heres-how-india-can-impact-its-future-earnings","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155306648","content_text":"The quest for more subscribers in the Streaming Wars has caused Netflix to lower its prices in India. But here's why this could be a good sign.\nIn the ongoing Streaming Wars, rival video giants have had to adopt different strategies in order to stay ahead of the competition.\nThat's certainly been the case with Netflix. This week, the company decided to cut subscription prices in India.\nWhile the South Asian country isn't Netflix's main target market, its performance there could be an important factor in predicting NFLX stock's future growth.\nLet's explore why.\nFigure 1: Netflix content focused on Indian audiences.\nWhat Did Netflix Do?\nNetflix slashed its subscription prices in India by 60% in a bid to stay ahead of its main competitors in that country -- namely, Disney and Amazon. For years, Netflix had been more expensive than its rivals in India.\nNetflix is hoping that its price cut will capture a larger market and ensure its dominance in the South Asian country.\nHere's a comparison of the current prices for streaming services in India:\nFigure 2: Streaming platforms prices on India.\n(US $ 1 = 75,8600 rupees)\nNetflix previously cost 499,000 rupees (roughly $6.60).\nWhy Did Netflix Cut Prices in India?\nIndia is the second most populous country in the world. Currently, around 1.4 billion people live there.\nHowever, not all of them have internet -- and, therefore, Netflix -- access.\nAccording to Statista, internet penetration in India is only 50%. However, that percentage is growing, motivating Netflix to invest in content streaming in the country.\nFigure 3: Internet penetration rate percentage in India.\nMarket Share: The Most Important Metric\nNetflix doesn't have the huge market share in India that it does in the U.S.\nFigure 4: India video streaming market share (Q2 2021).\nSo the company has been forced to try some aggressive strategies, such as lowering its subscription prices.\nEven if the lower prices result in profit loss, they could translate to a larger customer base in the massive Asian country. As more people come online in India, they have the potential to become an important source of revenue for the company.\nOur Take\nIn most cases, investors don't view price cuts as good moves. After all, they mean lower returns.\nHowever, in the case of companies that are still growing and gradually increasing their market share, it can be a good strategy.\nLooking specifically at Netflix, we think this could translate to long-term gains for the stock with little impact on NFLX in the short term.","news_type":1},"isVote":1,"tweetType":1,"viewCount":775,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693388493,"gmtCreate":1639971179809,"gmtModify":1639971179809,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693388493","repostId":"2192039709","repostType":4,"repost":{"id":"2192039709","kind":"highlight","pubTimestamp":1639970366,"share":"https://www.laohu8.com/m/news/2192039709?lang=&edition=full","pubTime":"2021-12-20 11:19","market":"us","language":"en","title":"Why inflation and the U.S. policy response will be key for markets in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2192039709","media":"MarketWatch","summary":"Federal Reserve's inflation battle in 2022 will hinge on economic growth\nHow the Federal Reserve and","content":"<p>Federal Reserve's inflation battle in 2022 will hinge on economic growth</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c9ff44f1cb6fee19f2a4a8710c451c8a\" tg-width=\"700\" tg-height=\"487\" referrerpolicy=\"no-referrer\"><span>How the Federal Reserve and policy makers in Washington react to inflation pressures will be a key factor for markets in the coming year.</span></p>\n<p>U.S. financial markets have been pretty smooth sailing for investors this year, with the Federal Reserve's easy-money policies helping to iron out rough patches during the pandemic.</p>\n<p>In the final weeks of December, the S&amp;P 500 index was up 23% on the year, while U.S. \"junk bond\" yields with speculative-grade&nbsp;ratings were near historic lows around 4.5% . The broad stock market rally has made it easy to draw links between soaring asset prices and the Fed's bond buying program and heaps of fiscal aid from Washington.</p>\n<p>But that's all about to change with Fed Chairman Jerome Powell now squarely focused on keeping sharply higher costs of living from derailing the U.S. economy, and with investors expecting 2022 to be when markets really get interesting.</p>\n<p>\"I think inflation is the variable for 2022, because that's going to be what drives policy,\" said Jim Caron, senior portfolio manager at <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> Investment Management, in a phone interview Friday. \"Policy has been driving asset performance.\"</p>\n<p>And with policy something of a wild card in the coming months, particularly as the government looks to tamp down price pressures, without hamstringing the economy, Caron said he's urging investors to keep some cash on hand for buying opportunities in what could be \"a very volatile and choppy year.\"</p>\n<p><b>Inflation matters, so does growth</b></p>\n<p>U.S. stocks tumbled to their worst weekly losses in three weeks Friday, after the Fed on Wednesday outlined more aggressive plans to end its massive bond-buying program and penciled in three benchmark interest rate increases next year.</p>\n<p>Over the next few months, investors will look for the U.S. central bank to engineer a soft landing for markets as it attempts to switch gears and tighten accommodative monetary policies to fight inflation running at 1980s levels, but also keep the economy advancing.</p>\n<p>Like Europe, the U.S. also may need to balance policy with potential economic setbacks as coronavirus variants begin to drive another startling wave of winter COVID-19 infections and restrictions on consumer and business activity.</p>\n<p>\"If GDP growth disappoints and inflation remains high, it will be tough for the Fed to raise rates 75 basis points next year,\" said D.A. Davidson's James Ragan, director of wealth management research.</p>\n<p>While Fed officials increased their 2022 GDP growth forecast to 4% next year from 3.8% earlier, still above the historical trend, that's lower than the 5.5% growth expected this year. \"That type of GDP growth should support Fed rate increases and higher long-term rates,\" Ragan said, in a phone interview. Although, with the 10-year Treasury yield near 1.4%, Ragan said the bond market has been exhibiting some doubts about how much room the Fed may have to interest raise rates in the next 12 months.</p>\n<p>\"I think bond investors are still concerned about long-term growth prospects, and a little worried that three rate hikes might be a little too much,\" he said.</p>\n<p>For stocks, Ragan worries about high valuations and uncertainty about future corporate earnings, particularly if inflation slows economic activity, consumers pull back spending or wage pressures translate to lower company earnings.</p>\n<p>\"That's something to keep an eye on in early 2022,\" he said.</p>\n<p><b>'Right thing' to do</b></p>\n<p>Stephen Philipson, head of U.S. Bank's&nbsp;fixed income and capital markets group, said the Fed's more \"aggressive stance is the right thing to do to counter stubborn inflation,\" particularly with so much liquidity sloshing through financial markets during the pandemic.</p>\n<p>Philipson said he also sees looming interest rate increases as a likely catalyst for U.S. investment-grade companies&nbsp;to refinance some $1.25 trillion in debt coming due from 2023 and 2025, with coupons above 3%.</p>\n<p>\"There's a meaningful amount of debt that could be pulled forward to refinance,\" he told MarketWatch. \"We've been calling for slightly down supply for the year, but I think with the Fed taking a more aggressive approach, it could accelerate refinancing of bonds coming due over the next few years.\"</p>\n<p>The Dow Jones Industrial Average ended a volatile week 1.7% lower, while the S&amp;P 500 ended down 1.9%. The Nasdaq Composite Index tumbled 3%, with all three booking the worst week of declines since Nov. 26, according to Dow Jones Market Data.</p>\n<p>Midweek, before Friday's Christmas Eve holiday, will see a fresh slate of U.S. economic data, including December's updated consumer confidence index and existing home sales on Wednesday. But it will be Thursday with a deluge that includes weekly initial jobless claims for the week of Dec. 18, but also November updates on core inflation, personal income, consumer spending, durable goods orders and more.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why inflation and the U.S. policy response will be key for markets in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy inflation and the U.S. policy response will be key for markets in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 11:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/why-inflation-and-the-u-s-policy-response-will-be-key-for-markets-in-2022-11639795830?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Federal Reserve's inflation battle in 2022 will hinge on economic growth\nHow the Federal Reserve and policy makers in Washington react to inflation pressures will be a key factor for markets in the ...</p>\n\n<a href=\"https://www.marketwatch.com/story/why-inflation-and-the-u-s-policy-response-will-be-key-for-markets-in-2022-11639795830?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4207":"综合性银行",".SPX":"S&P 500 Index","USB":"美国合众银行",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","BK4504":"桥水持仓","BK4550":"红杉资本持仓","BK4561":"索罗斯持仓","BK4559":"巴菲特持仓"},"source_url":"https://www.marketwatch.com/story/why-inflation-and-the-u-s-policy-response-will-be-key-for-markets-in-2022-11639795830?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192039709","content_text":"Federal Reserve's inflation battle in 2022 will hinge on economic growth\nHow the Federal Reserve and policy makers in Washington react to inflation pressures will be a key factor for markets in the coming year.\nU.S. financial markets have been pretty smooth sailing for investors this year, with the Federal Reserve's easy-money policies helping to iron out rough patches during the pandemic.\nIn the final weeks of December, the S&P 500 index was up 23% on the year, while U.S. \"junk bond\" yields with speculative-grade ratings were near historic lows around 4.5% . The broad stock market rally has made it easy to draw links between soaring asset prices and the Fed's bond buying program and heaps of fiscal aid from Washington.\nBut that's all about to change with Fed Chairman Jerome Powell now squarely focused on keeping sharply higher costs of living from derailing the U.S. economy, and with investors expecting 2022 to be when markets really get interesting.\n\"I think inflation is the variable for 2022, because that's going to be what drives policy,\" said Jim Caron, senior portfolio manager at Morgan Stanley Investment Management, in a phone interview Friday. \"Policy has been driving asset performance.\"\nAnd with policy something of a wild card in the coming months, particularly as the government looks to tamp down price pressures, without hamstringing the economy, Caron said he's urging investors to keep some cash on hand for buying opportunities in what could be \"a very volatile and choppy year.\"\nInflation matters, so does growth\nU.S. stocks tumbled to their worst weekly losses in three weeks Friday, after the Fed on Wednesday outlined more aggressive plans to end its massive bond-buying program and penciled in three benchmark interest rate increases next year.\nOver the next few months, investors will look for the U.S. central bank to engineer a soft landing for markets as it attempts to switch gears and tighten accommodative monetary policies to fight inflation running at 1980s levels, but also keep the economy advancing.\nLike Europe, the U.S. also may need to balance policy with potential economic setbacks as coronavirus variants begin to drive another startling wave of winter COVID-19 infections and restrictions on consumer and business activity.\n\"If GDP growth disappoints and inflation remains high, it will be tough for the Fed to raise rates 75 basis points next year,\" said D.A. Davidson's James Ragan, director of wealth management research.\nWhile Fed officials increased their 2022 GDP growth forecast to 4% next year from 3.8% earlier, still above the historical trend, that's lower than the 5.5% growth expected this year. \"That type of GDP growth should support Fed rate increases and higher long-term rates,\" Ragan said, in a phone interview. Although, with the 10-year Treasury yield near 1.4%, Ragan said the bond market has been exhibiting some doubts about how much room the Fed may have to interest raise rates in the next 12 months.\n\"I think bond investors are still concerned about long-term growth prospects, and a little worried that three rate hikes might be a little too much,\" he said.\nFor stocks, Ragan worries about high valuations and uncertainty about future corporate earnings, particularly if inflation slows economic activity, consumers pull back spending or wage pressures translate to lower company earnings.\n\"That's something to keep an eye on in early 2022,\" he said.\n'Right thing' to do\nStephen Philipson, head of U.S. Bank's fixed income and capital markets group, said the Fed's more \"aggressive stance is the right thing to do to counter stubborn inflation,\" particularly with so much liquidity sloshing through financial markets during the pandemic.\nPhilipson said he also sees looming interest rate increases as a likely catalyst for U.S. investment-grade companies to refinance some $1.25 trillion in debt coming due from 2023 and 2025, with coupons above 3%.\n\"There's a meaningful amount of debt that could be pulled forward to refinance,\" he told MarketWatch. \"We've been calling for slightly down supply for the year, but I think with the Fed taking a more aggressive approach, it could accelerate refinancing of bonds coming due over the next few years.\"\nThe Dow Jones Industrial Average ended a volatile week 1.7% lower, while the S&P 500 ended down 1.9%. The Nasdaq Composite Index tumbled 3%, with all three booking the worst week of declines since Nov. 26, according to Dow Jones Market Data.\nMidweek, before Friday's Christmas Eve holiday, will see a fresh slate of U.S. economic data, including December's updated consumer confidence index and existing home sales on Wednesday. But it will be Thursday with a deluge that includes weekly initial jobless claims for the week of Dec. 18, but also November updates on core inflation, personal income, consumer spending, durable goods orders and more.","news_type":1},"isVote":1,"tweetType":1,"viewCount":773,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699229721,"gmtCreate":1639815804572,"gmtModify":1639815805376,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699229721","repostId":"2192754259","repostType":2,"isVote":1,"tweetType":1,"viewCount":454,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690428907,"gmtCreate":1639703201782,"gmtModify":1639703201846,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"Notes","listText":"Notes","text":"Notes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690428907","repostId":"2192947044","repostType":4,"repost":{"id":"2192947044","kind":"highlight","pubTimestamp":1639699547,"share":"https://www.laohu8.com/m/news/2192947044?lang=&edition=full","pubTime":"2021-12-17 08:05","market":"us","language":"en","title":"Oracle in talks to buy Cerner","url":"https://stock-news.laohu8.com/highlight/detail?id=2192947044","media":"The Wall Street Journal","summary":"Oracle Corp. ORCL -0.41% is in talks to buy electronic-medical-records company Cerner Corp. CERN 0.7","content":"<p>Oracle Corp. ORCL -0.41% is in talks to buy electronic-medical-records company Cerner Corp. CERN 0.72% , according to people familiar with the matter, a deal that could be worth around $30 billion and push the enterprise-software giant further into healthcare.</p>\n<p></p>\n<p>An agreement could be finalized soon, some of the people said, assuming the talks don’t fall apart or drag out. Should a deal come together, it would rank as the biggest ever for Oracle, which has a market value of more than $280 billion.</p>\n<p></p>\n<p>Kansas City, Mo.-based Cerner designs software that hospitals and doctors use to store and analyze medical records and other healthcare data. It has a market value of around $23 billion. With a typical takeover premium, a deal would be expected to value the company at something like $30 billion, though exact terms being discussed couldn’t be learned.</p>\n<p></p>\n<p>Oracle, a Silicon Valley veteran that last year moved its headquarters to Austin, Texas, is one of the biggest software providers to other companies and organizations.</p>\n<p>In August, Cerner tapped David Feinberg as chief executive officer, a role he assumed in October. Mr. Feinberg came from Oracle rival Google, where he had led the Alphabet Inc. unit’s push into healthcare and helped strike partnerships with some of the country’s largest hospital systems to collect and analyze their data.</p>\n<p></p>\n<p>Oracle already has a significant presence in healthcare, offering technology meant to help health insurers, healthcare providers and public health systems parse data to increase efficiency and improve patient outcomes.</p>\n<p></p>\n<p></p>\n<p>Oracle shares closed Thursday at $103.22, down slightly amid a broad-based tech selloff and just off an all-time high reached the day before. They jumped over 15% last week when the company reported fiscal-second-quarter results that topped estimates and Chief Executive Safra Catz reiterated the expectation that full-year revenue growth would accelerate from the year earlier. Ms. Catz, who became the sole CEO in 2019, said she expects the company’s operating margins to be the same or better than they were pre-pandemic.</p>\n<p></p>\n<p>The company also increased the authorization for share repurchases by $10 billion.</p>\n<p></p>\n<p>Buying Cerner could help Oracle with its pivot toward the cloud. Investors have warmed to Oracle as the company ramps up its focus on winning cloud-computing business, after initially being slow to embrace the booming market for storing and analyzing data on remote servers. Oracle has been trying to make up ground in recent years after falling behind companies such as Amazon.com Inc. and Microsoft Corp. , which both now have market values well exceeding $1 trillion thanks in part to thriving cloud units.</p>\n<p></p>\n<p>A deal for Cerner would follow Microsoft’s agreement in April to buy artificial-intelligence company Nuance Communications Inc. for $16 billion, in a bet on the growing demand for digital healthcare tools.</p>\n<p></p>\n<p>Oracle was founded by outspoken billionaire Larry Ellison and others in 1977. Mr. Ellison owns roughly 42% of the company’s shares, a stake that is worth well over $100 billion. Mr. Ellison passed the CEO reins to Ms. Catz and the late Mark Hurd in 2014, but remains chairman and chief technology officer.</p>\n<p></p>\n<p>A deal for Cerner would easily top Oracle’s next-largest transaction, the roughly $10 billion purchase of enterprise-software firm PeopleSoft Inc. that closed in 2005, followed by a $9 billion deal for cloud-software provider NetSuite Inc. in 2016.</p>\n<p></p>\n<p>In 2020, Oracle showed an appetite for bigger deals when it beat out Microsoft in bidding for the video-sharing app TikTok’s U.S. operations. The Trump administration’s concerns about TikTok’s Chinese ownership had effectively put the business in play, but the deal was put on hold indefinitely by the Biden administration.</p>\n<p></p>\n<p>Cerner, founded in 1979, competes with the likes of privately held Epic Systems Corp. and Athenahealth Inc., which recently agreed to a sale to one group of private-equity firms by another for around $17 billion including debt.</p>\n<p></p>\n<p>Cerner shares rose slightly to $79.49 Thursday.</p>\n<p></p>\n<p></p>\n<p>An Oracle-Cerner deal would rank as one of the largest takeovers of 2021, which is shaping up to be one of the busiest ever for mergers and acquisitions. Merger activity in the U.S. is up 78% to $2.45 trillion, according to Dealogic, as lofty stock prices and easy money embolden companies to strike deals and special-purpose acquisition companies are formed at a breakneck pace.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oracle in talks to buy Cerner</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOracle in talks to buy Cerner\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 08:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/oracle-in-talks-to-buy-cerner-11639697730?mod=hp_lead_pos2><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Oracle Corp. ORCL -0.41% is in talks to buy electronic-medical-records company Cerner Corp. CERN 0.72% , according to people familiar with the matter, a deal that could be worth around $30 billion and...</p>\n\n<a href=\"https://www.wsj.com/articles/oracle-in-talks-to-buy-cerner-11639697730?mod=hp_lead_pos2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4167":"医疗保健技术","CERN":"美国塞纳","ORCL":"甲骨文","BK4538":"云计算","BK4534":"瑞士信贷持仓","BK4097":"系统软件","BK4528":"SaaS概念","BK4516":"特朗普概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4504":"桥水持仓"},"source_url":"https://www.wsj.com/articles/oracle-in-talks-to-buy-cerner-11639697730?mod=hp_lead_pos2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192947044","content_text":"Oracle Corp. ORCL -0.41% is in talks to buy electronic-medical-records company Cerner Corp. CERN 0.72% , according to people familiar with the matter, a deal that could be worth around $30 billion and push the enterprise-software giant further into healthcare.\n\nAn agreement could be finalized soon, some of the people said, assuming the talks don’t fall apart or drag out. Should a deal come together, it would rank as the biggest ever for Oracle, which has a market value of more than $280 billion.\n\nKansas City, Mo.-based Cerner designs software that hospitals and doctors use to store and analyze medical records and other healthcare data. It has a market value of around $23 billion. With a typical takeover premium, a deal would be expected to value the company at something like $30 billion, though exact terms being discussed couldn’t be learned.\n\nOracle, a Silicon Valley veteran that last year moved its headquarters to Austin, Texas, is one of the biggest software providers to other companies and organizations.\nIn August, Cerner tapped David Feinberg as chief executive officer, a role he assumed in October. Mr. Feinberg came from Oracle rival Google, where he had led the Alphabet Inc. unit’s push into healthcare and helped strike partnerships with some of the country’s largest hospital systems to collect and analyze their data.\n\nOracle already has a significant presence in healthcare, offering technology meant to help health insurers, healthcare providers and public health systems parse data to increase efficiency and improve patient outcomes.\n\n\nOracle shares closed Thursday at $103.22, down slightly amid a broad-based tech selloff and just off an all-time high reached the day before. They jumped over 15% last week when the company reported fiscal-second-quarter results that topped estimates and Chief Executive Safra Catz reiterated the expectation that full-year revenue growth would accelerate from the year earlier. Ms. Catz, who became the sole CEO in 2019, said she expects the company’s operating margins to be the same or better than they were pre-pandemic.\n\nThe company also increased the authorization for share repurchases by $10 billion.\n\nBuying Cerner could help Oracle with its pivot toward the cloud. Investors have warmed to Oracle as the company ramps up its focus on winning cloud-computing business, after initially being slow to embrace the booming market for storing and analyzing data on remote servers. Oracle has been trying to make up ground in recent years after falling behind companies such as Amazon.com Inc. and Microsoft Corp. , which both now have market values well exceeding $1 trillion thanks in part to thriving cloud units.\n\nA deal for Cerner would follow Microsoft’s agreement in April to buy artificial-intelligence company Nuance Communications Inc. for $16 billion, in a bet on the growing demand for digital healthcare tools.\n\nOracle was founded by outspoken billionaire Larry Ellison and others in 1977. Mr. Ellison owns roughly 42% of the company’s shares, a stake that is worth well over $100 billion. Mr. Ellison passed the CEO reins to Ms. Catz and the late Mark Hurd in 2014, but remains chairman and chief technology officer.\n\nA deal for Cerner would easily top Oracle’s next-largest transaction, the roughly $10 billion purchase of enterprise-software firm PeopleSoft Inc. that closed in 2005, followed by a $9 billion deal for cloud-software provider NetSuite Inc. in 2016.\n\nIn 2020, Oracle showed an appetite for bigger deals when it beat out Microsoft in bidding for the video-sharing app TikTok’s U.S. operations. The Trump administration’s concerns about TikTok’s Chinese ownership had effectively put the business in play, but the deal was put on hold indefinitely by the Biden administration.\n\nCerner, founded in 1979, competes with the likes of privately held Epic Systems Corp. and Athenahealth Inc., which recently agreed to a sale to one group of private-equity firms by another for around $17 billion including debt.\n\nCerner shares rose slightly to $79.49 Thursday.\n\n\nAn Oracle-Cerner deal would rank as one of the largest takeovers of 2021, which is shaping up to be one of the busiest ever for mergers and acquisitions. Merger activity in the U.S. is up 78% to $2.45 trillion, according to Dealogic, as lofty stock prices and easy money embolden companies to strike deals and special-purpose acquisition companies are formed at a breakneck pace.","news_type":1},"isVote":1,"tweetType":1,"viewCount":469,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690423242,"gmtCreate":1639703082490,"gmtModify":1639703082594,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"Ok, noted","listText":"Ok, noted","text":"Ok, noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690423242","repostId":"1172405131","repostType":2,"isVote":1,"tweetType":1,"viewCount":613,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690057053,"gmtCreate":1639616325850,"gmtModify":1639616325850,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"☺️","listText":"☺️","text":"☺️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/690057053","repostId":"2191994940","repostType":4,"isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690054256,"gmtCreate":1639616278800,"gmtModify":1639616278800,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"✌️✌️✌️","listText":"✌️✌️✌️","text":"✌️✌️✌️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690054256","repostId":"1192225285","repostType":2,"isVote":1,"tweetType":1,"viewCount":708,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607871071,"gmtCreate":1639528893605,"gmtModify":1639528893605,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"🤔🤔🤔","listText":"🤔🤔🤔","text":"🤔🤔🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607871071","repostId":"2191784951","repostType":4,"isVote":1,"tweetType":1,"viewCount":627,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607924086,"gmtCreate":1639477703329,"gmtModify":1639477703448,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"🤔🤔🤔","listText":"🤔🤔🤔","text":"🤔🤔🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607924086","repostId":"1173824820","repostType":4,"repost":{"id":"1173824820","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639406936,"share":"https://www.laohu8.com/m/news/1173824820?lang=&edition=full","pubTime":"2021-12-13 22:48","market":"us","language":"en","title":"Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1173824820","media":"Tiger Newspress","summary":"Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion.On Decem","content":"<p>Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion.<img src=\"https://static.tigerbbs.com/2541d11930fa271c03180dbe4f2b3f76\" tg-width=\"776\" tg-height=\"557\" width=\"100%\" height=\"auto\">On December 9th, EST, Nubank, a Latin American digital banking giant, landed on the New York Stock Exchange, with an issue price of US $9 and a surge of 36% at the opening. According to the market value of US $47.6 billion after hours, Nubank is already the largest listed bank in Latin America.</p>\n<p>The company said it had a $99 million loss on revenue of $1.06 billion for the nine-month period ended Sept. 30. Interest income accounted for $607 million of that revenue, with fees and commissions making up the remainder.</p>\n<p>Nubank warned investors to brace for “short-term profit implications” from the firm’s expansion push.</p>\n<p>Chief Executive Officer David Velez will own a stake in the company worth about $8.9 billion at the IPO price. His co-founder, Cristina Junqueira, has a stake worth $1.1 billion.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNu Holdings slid over 8% in morning trading,with its market value falling below $50 billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 22:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion.<img src=\"https://static.tigerbbs.com/2541d11930fa271c03180dbe4f2b3f76\" tg-width=\"776\" tg-height=\"557\" width=\"100%\" height=\"auto\">On December 9th, EST, Nubank, a Latin American digital banking giant, landed on the New York Stock Exchange, with an issue price of US $9 and a surge of 36% at the opening. According to the market value of US $47.6 billion after hours, Nubank is already the largest listed bank in Latin America.</p>\n<p>The company said it had a $99 million loss on revenue of $1.06 billion for the nine-month period ended Sept. 30. Interest income accounted for $607 million of that revenue, with fees and commissions making up the remainder.</p>\n<p>Nubank warned investors to brace for “short-term profit implications” from the firm’s expansion push.</p>\n<p>Chief Executive Officer David Velez will own a stake in the company worth about $8.9 billion at the IPO price. His co-founder, Cristina Junqueira, has a stake worth $1.1 billion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NU":"Nu Holdings Ltd."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173824820","content_text":"Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion.On December 9th, EST, Nubank, a Latin American digital banking giant, landed on the New York Stock Exchange, with an issue price of US $9 and a surge of 36% at the opening. According to the market value of US $47.6 billion after hours, Nubank is already the largest listed bank in Latin America.\nThe company said it had a $99 million loss on revenue of $1.06 billion for the nine-month period ended Sept. 30. Interest income accounted for $607 million of that revenue, with fees and commissions making up the remainder.\nNubank warned investors to brace for “short-term profit implications” from the firm’s expansion push.\nChief Executive Officer David Velez will own a stake in the company worth about $8.9 billion at the IPO price. His co-founder, Cristina Junqueira, has a stake worth $1.1 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":567,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602401104,"gmtCreate":1639051088022,"gmtModify":1639051227812,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582126034262927","authorIdStr":"3582126034262927"},"themes":[],"htmlText":"😲😲😲","listText":"😲😲😲","text":"😲😲😲","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602401104","repostId":"2190503698","repostType":4,"repost":{"id":"2190503698","kind":"highlight","pubTimestamp":1639038865,"share":"https://www.laohu8.com/m/news/2190503698?lang=&edition=full","pubTime":"2021-12-09 16:34","market":"us","language":"en","title":"'Proceed with caution': here's what Wall Street analysts see for the U.S. stock market in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2190503698","media":"MarketWatch","summary":"'2022 will be a critical year when the imbalances wrought by the global pandemic begin to resolve an","content":"<p>'2022 will be a critical year when the imbalances wrought by the global pandemic begin to resolve and the business cycle normalizes from extremes,' says <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>'s Lisa Shalett</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/71e96005daaaf18cef4eb11fc31ef1c7\" tg-width=\"700\" tg-height=\"487\" referrerpolicy=\"no-referrer\"><span>‘Marginally tighter monetary policy’ should be a headwind for markets in 2022, JPMorgan strategists say</span></p>\n<p>The recent spike in market volatility may herald a bumpier U.S. stock market in 2022, as investors come to grips with an inflection point in monetary policy in the pandemic.</p>\n<p>\"There probably will be some elevated volatility around the potential tightening of Fed policy,\" said Shawn Snyder, head of investment strategy at Citigroup's U.S. consumer wealth management division, in a phone interview. \"Omicron throws in a bit of a wrench\" to the 2022 outlook, he said of the new variant of the coronavirus, though investors have appeared encouraged by some early signs that it may be less dangerous than initially feared.</p>\n<p>The CBOE Volatility Index , or VIX, jumped in late November and remains above its 200-day moving average even after subsiding since last week, according to FactSet data. The VIX broke above 30 last week for the first time since the first quarter of 2021, the data show, amid market jitters over the emergence of omicron and the potential move by the Federal Reserve to remove some accommodation from the market faster than investors had anticipated.</p>\n<p>\"That's a big transition that creates tension for investors,\" said Lauren Goodwin, economist and director of portfolio strategy at New York Life Investment, in a phone interview. The Fed looks to be positioning for more flexibility for potential interest rate hikes next year, with increased inflationary pressure likely to mean more rate rises in 2022 than currently expected, creating more market risk, she said.</p>\n<p>Some investors worry that interest rate-sensitive growth and technology stocks would be particularly vulnerable should the Fed aggressively tighten its monetary policy through rate hikes. The S&amp;P 500 index, which has a large exposure to tech, is on track for a third straight year of strong gains after rising almost 25% in 2021 through Tuesday, according to FactSet.</p>\n<p>The U.S. stock market will probably deliver more modest gains \"accompanied by higher volatility\" next year, Jeffrey Kleintop, chief global investment strategist at Charles Schwab, told MarketWatch by phone.</p>\n<p>Goodwin said she also expects increased volatility, amid transitions that include the fading of the fiscal stimulus that provided direct support to consumers during the COVID-19 crisis and the Fed taking its \"foot off the gas\" in the economic recovery. She expects \"much lower\" stock-market returns next year compared to gains so far in 2021.</p>\n<p>\"Most of the equity upside should be realized between now\" and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest,\" JPMorgan Chase &amp; Co. strategists said in a 2022 outlook report Wednesday.</p>\n<p>Wall Street banks have been rolling out their 2022 forecasts for the S&amp;P 500, with Goldman Sachs Group and JPMorgan being among the most bullish on U.S. stocks.</p>\n<p>Goldman expects the S&amp;P 500 will end 2022 at 5,100, according to a portfolio strategy research report from the bank dated Dec. 3. Meanwhile, JPMorgan analysts predicted in a research report at the end of November that the U.S. stock benchmark will rise next year to 5,050, partly on \"robust earnings growth\" and easing supply chain woes. RBC Capital Markets has forecast the same price target as JPMorgan, while Deutsche Bank predicts the S&amp;P 500 will end next year at 5,000, according to a slide presentation from its chief investment office.</p>\n<p>Meanwhile, Citigroup set an S&amp;P 500 target of 4,900 for the end of 2022, a research report from the bank in late October shows. Coming in below that level, Barclays predicted in a U.S. equity strategy report this month that the index will finish next year at 4,800.</p>\n<p>\"Proceed with caution,\" the Barclays analysts wrote in their 2022 outlook report dated Dec. 2. \"We see limited upside for equities next year,\" they said. In their view, \"household and corporate cash hoards should support modest earnings growth but persistent supply chain woes, reversal of goods consumption to trend&nbsp;are key tail risks.\"</p>\n<p>Bank of America's analysts have a lower price target than Barclays for the S&amp;P 500 next year, with a BofA Global Research report last month showing the benchmark will end 2022 at 4,600.</p>\n<p>\"Unfortunately we see a lot of similarities between today and 2000 -- the tech bubble peak,\" said Savita Subramanian, head of equity and quant strategy at BofA, during a late November media briefing on their U.S. stock market outlook.</p>\n<p>Morgan Stanley has a more bearish outlook for next year that puts the S&amp;P 500 below the index's close Tuesday at 4,686.75. A report Monday from the bank's wealth management division shows a base-case forecast of 4,400 for the S&amp;P 500 at the end of 2022 even with an expected gain in earnings.</p>\n<p>\"We expect the S&amp;P 500 to be range-bound and volatile, and bond returns to be negative net of inflation,\" said Lisa Shalett, chief investment officer at Morgan Stanley Wealth Management, in the note. \"Fixed income should be reduced to fund greater exposure to real assets and to absolute return funds.\"</p>\n<p>The core of Morgan Stanley's \"cautious\" view on the S&amp;P 500 is based on price-to-earnings ratios typically compressing during \"a midcycle transition,\" Shalett said. She pointed to a chart in her note showing that \"median stock has traversed the midcycle transition.\"</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/641e64a82babbbd377cb43247c437118\" tg-width=\"700\" tg-height=\"397\" referrerpolicy=\"no-referrer\"><span>MORGAN STANLEY WEALTH MANAGEMENT REPORT DATED DEC. 6, 2021</span></p>\n<p>The chart shows \"the median S&amp;P 500 stock has corrected 15% from its 52-week high,\" but the index has been kept aloft by the 15 largest companies now accounting for 40% of its market capitalization, according to her note.</p>\n<p>\"While they may be great companies, we are less convinced they will all be great stocks in 2022 as financial conditions tighten, interest rates rise, employment costs increase and inflation remains challenging,\" Shalett said. \"We think profit margins for the top 15 have peaked.\"</p>\n<p>In Morgan Stanley's view, \"this suggests investors should move toward stock picking and away from passive index funds,\" her note shows.</p>\n<p>JPMorgan expects that \"international equities, emerging markets and cyclical market segments will significantly outperform,\" according to its report Wednesday.</p>\n<p>\"The reason for this is our expectation for increasing interest rates and marginally tighter monetary policy that should be a headwind for high-multiple markets such as the Nasdaq,\" the JPMorgan strategists wrote, citing the tech-laden Nasdaq Composite Index .</p>\n<p>Citi's Snyder told MarketWatch that during \"midcycle\" he likes high-quality stocks, \"dividend-growers\" and global healthcare equities. Consistent earnings growth and \"reasonable valuations\" make healthcare attractive, he said, and stock bets in the area can serve as \"a volatility dampener\" in portfolios.</p>\n<p>Immunology is one of three megatrends poised to accelerate next year as \"a range of next-gen oncological therapeutics come up for approval and enable more targeted cancer treatment,\" according to Jeff Spiegel, head of U.S. iShares megatrend and international ETFs. Shares of the iShares Genomics Immunology and Healthcare ETF&nbsp;were up about 0.2% this year based on midday trading Wednesday, FactSet data show, at last check.</p>\n<p>Two other megatrends to watch in 2022 are \"digital transformation\" intensifying through the cloud, 5G and cybersecurity, and \"automation technologies\" such as robotics and artificial intelligence, Spiegel wrote in a report this month. Automation technologies should grow \"in response to ongoing supply chain bottlenecks and wage inflation\" in the pandemic, he wrote.</p>\n<p>\"I think we'll actually be dealing with gluts next year rather than shortages,\" said Charles Schwab's Kleintop. \"That will help drive down inflation, particularly in the second half of next year, making an aggressive path of rate hikes unlikely.\"</p>\n<p>The market is expecting three rate hikes by the U.S. central bank in 2022 after Fed Chair Jerome Powell signaled last week that it may speed up the tapering of its monthly asset purchases, said Deepak Puri, Deutsche Bank's CIO for the America, during a media briefing Monday on his outlook for next year.</p>\n<p>While the Fed may become more aggressive in tapering its bond purchases, potentially completing the process in March instead of June, said Puri, he expects the Fed will still be \"dovish\" on rates next year. Puri forecasts that the Fed will raise rates just once next year, which is below consensus, he said.</p>\n<p>\"We expect two rate hikes next year,\" said New York Life Investment's Goodwin.</p>\n<p>Morgan Stanley's Shalett wrote in her 2022 outlook note that \"we see a classic reflationary rebalancing in which higher nominal and real rates reflect higher average growth and inflation rates.\" She also expects yield curves will steepen, profit margins to be squeezed by rising costs, and price-to-earnings ratios to compress in \"rate-sensitive sectors.\"</p>\n<p>\"Within the U.S., we like reopening and reflationary themes and beneficiaries of higher bond yields,\" JPMorgan said in its report Wednesday. The bank's strategists expect the yield on the 10-year Treasury note will rise to 2.25% by the end of next year, the report shows.</p>\n<p>\"Our view is that 2022 will be the year of a full global recovery, an end of the global pandemic, and a return to normal conditions we had prior to the COVID-19 outbreak,\" Marko Kolanovic, chief global markets strategist at JPMorgan, and the bank's global co-head of research Hussein Malik wrote in the report Wednesday.</p>\n<p>According to Shalett, \"on most counts, 2022 will be a critical year when the imbalances wrought by the global pandemic begin to resolve and the business cycle normalizes from extremes.\"</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>'Proceed with caution': here's what Wall Street analysts see for the U.S. stock market in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n'Proceed with caution': here's what Wall Street analysts see for the U.S. stock market in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-09 16:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/proceed-with-caution-heres-what-wall-street-analysts-see-for-the-u-s-stock-market-in-2022-11638986154?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>'2022 will be a critical year when the imbalances wrought by the global pandemic begin to resolve and the business cycle normalizes from extremes,' says Morgan Stanley's Lisa Shalett\n‘Marginally ...</p>\n\n<a href=\"https://www.marketwatch.com/story/proceed-with-caution-heres-what-wall-street-analysts-see-for-the-u-s-stock-market-in-2022-11638986154?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/proceed-with-caution-heres-what-wall-street-analysts-see-for-the-u-s-stock-market-in-2022-11638986154?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190503698","content_text":"'2022 will be a critical year when the imbalances wrought by the global pandemic begin to resolve and the business cycle normalizes from extremes,' says Morgan Stanley's Lisa Shalett\n‘Marginally tighter monetary policy’ should be a headwind for markets in 2022, JPMorgan strategists say\nThe recent spike in market volatility may herald a bumpier U.S. stock market in 2022, as investors come to grips with an inflection point in monetary policy in the pandemic.\n\"There probably will be some elevated volatility around the potential tightening of Fed policy,\" said Shawn Snyder, head of investment strategy at Citigroup's U.S. consumer wealth management division, in a phone interview. \"Omicron throws in a bit of a wrench\" to the 2022 outlook, he said of the new variant of the coronavirus, though investors have appeared encouraged by some early signs that it may be less dangerous than initially feared.\nThe CBOE Volatility Index , or VIX, jumped in late November and remains above its 200-day moving average even after subsiding since last week, according to FactSet data. The VIX broke above 30 last week for the first time since the first quarter of 2021, the data show, amid market jitters over the emergence of omicron and the potential move by the Federal Reserve to remove some accommodation from the market faster than investors had anticipated.\n\"That's a big transition that creates tension for investors,\" said Lauren Goodwin, economist and director of portfolio strategy at New York Life Investment, in a phone interview. The Fed looks to be positioning for more flexibility for potential interest rate hikes next year, with increased inflationary pressure likely to mean more rate rises in 2022 than currently expected, creating more market risk, she said.\nSome investors worry that interest rate-sensitive growth and technology stocks would be particularly vulnerable should the Fed aggressively tighten its monetary policy through rate hikes. The S&P 500 index, which has a large exposure to tech, is on track for a third straight year of strong gains after rising almost 25% in 2021 through Tuesday, according to FactSet.\nThe U.S. stock market will probably deliver more modest gains \"accompanied by higher volatility\" next year, Jeffrey Kleintop, chief global investment strategist at Charles Schwab, told MarketWatch by phone.\nGoodwin said she also expects increased volatility, amid transitions that include the fading of the fiscal stimulus that provided direct support to consumers during the COVID-19 crisis and the Fed taking its \"foot off the gas\" in the economic recovery. She expects \"much lower\" stock-market returns next year compared to gains so far in 2021.\n\"Most of the equity upside should be realized between now\" and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest,\" JPMorgan Chase & Co. strategists said in a 2022 outlook report Wednesday.\nWall Street banks have been rolling out their 2022 forecasts for the S&P 500, with Goldman Sachs Group and JPMorgan being among the most bullish on U.S. stocks.\nGoldman expects the S&P 500 will end 2022 at 5,100, according to a portfolio strategy research report from the bank dated Dec. 3. Meanwhile, JPMorgan analysts predicted in a research report at the end of November that the U.S. stock benchmark will rise next year to 5,050, partly on \"robust earnings growth\" and easing supply chain woes. RBC Capital Markets has forecast the same price target as JPMorgan, while Deutsche Bank predicts the S&P 500 will end next year at 5,000, according to a slide presentation from its chief investment office.\nMeanwhile, Citigroup set an S&P 500 target of 4,900 for the end of 2022, a research report from the bank in late October shows. Coming in below that level, Barclays predicted in a U.S. equity strategy report this month that the index will finish next year at 4,800.\n\"Proceed with caution,\" the Barclays analysts wrote in their 2022 outlook report dated Dec. 2. \"We see limited upside for equities next year,\" they said. In their view, \"household and corporate cash hoards should support modest earnings growth but persistent supply chain woes, reversal of goods consumption to trend are key tail risks.\"\nBank of America's analysts have a lower price target than Barclays for the S&P 500 next year, with a BofA Global Research report last month showing the benchmark will end 2022 at 4,600.\n\"Unfortunately we see a lot of similarities between today and 2000 -- the tech bubble peak,\" said Savita Subramanian, head of equity and quant strategy at BofA, during a late November media briefing on their U.S. stock market outlook.\nMorgan Stanley has a more bearish outlook for next year that puts the S&P 500 below the index's close Tuesday at 4,686.75. A report Monday from the bank's wealth management division shows a base-case forecast of 4,400 for the S&P 500 at the end of 2022 even with an expected gain in earnings.\n\"We expect the S&P 500 to be range-bound and volatile, and bond returns to be negative net of inflation,\" said Lisa Shalett, chief investment officer at Morgan Stanley Wealth Management, in the note. \"Fixed income should be reduced to fund greater exposure to real assets and to absolute return funds.\"\nThe core of Morgan Stanley's \"cautious\" view on the S&P 500 is based on price-to-earnings ratios typically compressing during \"a midcycle transition,\" Shalett said. She pointed to a chart in her note showing that \"median stock has traversed the midcycle transition.\"\nMORGAN STANLEY WEALTH MANAGEMENT REPORT DATED DEC. 6, 2021\nThe chart shows \"the median S&P 500 stock has corrected 15% from its 52-week high,\" but the index has been kept aloft by the 15 largest companies now accounting for 40% of its market capitalization, according to her note.\n\"While they may be great companies, we are less convinced they will all be great stocks in 2022 as financial conditions tighten, interest rates rise, employment costs increase and inflation remains challenging,\" Shalett said. \"We think profit margins for the top 15 have peaked.\"\nIn Morgan Stanley's view, \"this suggests investors should move toward stock picking and away from passive index funds,\" her note shows.\nJPMorgan expects that \"international equities, emerging markets and cyclical market segments will significantly outperform,\" according to its report Wednesday.\n\"The reason for this is our expectation for increasing interest rates and marginally tighter monetary policy that should be a headwind for high-multiple markets such as the Nasdaq,\" the JPMorgan strategists wrote, citing the tech-laden Nasdaq Composite Index .\nCiti's Snyder told MarketWatch that during \"midcycle\" he likes high-quality stocks, \"dividend-growers\" and global healthcare equities. Consistent earnings growth and \"reasonable valuations\" make healthcare attractive, he said, and stock bets in the area can serve as \"a volatility dampener\" in portfolios.\nImmunology is one of three megatrends poised to accelerate next year as \"a range of next-gen oncological therapeutics come up for approval and enable more targeted cancer treatment,\" according to Jeff Spiegel, head of U.S. iShares megatrend and international ETFs. Shares of the iShares Genomics Immunology and Healthcare ETF were up about 0.2% this year based on midday trading Wednesday, FactSet data show, at last check.\nTwo other megatrends to watch in 2022 are \"digital transformation\" intensifying through the cloud, 5G and cybersecurity, and \"automation technologies\" such as robotics and artificial intelligence, Spiegel wrote in a report this month. Automation technologies should grow \"in response to ongoing supply chain bottlenecks and wage inflation\" in the pandemic, he wrote.\n\"I think we'll actually be dealing with gluts next year rather than shortages,\" said Charles Schwab's Kleintop. \"That will help drive down inflation, particularly in the second half of next year, making an aggressive path of rate hikes unlikely.\"\nThe market is expecting three rate hikes by the U.S. central bank in 2022 after Fed Chair Jerome Powell signaled last week that it may speed up the tapering of its monthly asset purchases, said Deepak Puri, Deutsche Bank's CIO for the America, during a media briefing Monday on his outlook for next year.\nWhile the Fed may become more aggressive in tapering its bond purchases, potentially completing the process in March instead of June, said Puri, he expects the Fed will still be \"dovish\" on rates next year. Puri forecasts that the Fed will raise rates just once next year, which is below consensus, he said.\n\"We expect two rate hikes next year,\" said New York Life Investment's Goodwin.\nMorgan Stanley's Shalett wrote in her 2022 outlook note that \"we see a classic reflationary rebalancing in which higher nominal and real rates reflect higher average growth and inflation rates.\" She also expects yield curves will steepen, profit margins to be squeezed by rising costs, and price-to-earnings ratios to compress in \"rate-sensitive sectors.\"\n\"Within the U.S., we like reopening and reflationary themes and beneficiaries of higher bond yields,\" JPMorgan said in its report Wednesday. The bank's strategists expect the yield on the 10-year Treasury note will rise to 2.25% by the end of next year, the report shows.\n\"Our view is that 2022 will be the year of a full global recovery, an end of the global pandemic, and a return to normal conditions we had prior to the COVID-19 outbreak,\" Marko Kolanovic, chief global markets strategist at JPMorgan, and the bank's global co-head of research Hussein Malik wrote in the report Wednesday.\nAccording to Shalett, \"on most counts, 2022 will be a critical year when the imbalances wrought by the global pandemic begin to resolve and the business cycle normalizes from extremes.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":612,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":690057053,"gmtCreate":1639616325850,"gmtModify":1639616325850,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"☺️","listText":"☺️","text":"☺️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/690057053","repostId":"2191994940","repostType":4,"isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698214842,"gmtCreate":1640404859740,"gmtModify":1640404859857,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698214842","repostId":"2193720178","repostType":2,"isVote":1,"tweetType":1,"viewCount":1797,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698424747,"gmtCreate":1640503796905,"gmtModify":1640503796987,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698424747","repostId":"2193781141","repostType":4,"isVote":1,"tweetType":1,"viewCount":1497,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690423242,"gmtCreate":1639703082490,"gmtModify":1639703082594,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"Ok, noted","listText":"Ok, noted","text":"Ok, noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690423242","repostId":"1172405131","repostType":2,"isVote":1,"tweetType":1,"viewCount":613,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698867692,"gmtCreate":1640343626830,"gmtModify":1640343654207,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698867692","repostId":"2193414198","repostType":2,"isVote":1,"tweetType":1,"viewCount":1215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699229721,"gmtCreate":1639815804572,"gmtModify":1639815805376,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699229721","repostId":"2192754259","repostType":2,"isVote":1,"tweetType":1,"viewCount":454,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607871071,"gmtCreate":1639528893605,"gmtModify":1639528893605,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"🤔🤔🤔","listText":"🤔🤔🤔","text":"🤔🤔🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607871071","repostId":"2191784951","repostType":4,"isVote":1,"tweetType":1,"viewCount":627,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693388493,"gmtCreate":1639971179809,"gmtModify":1639971179809,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693388493","repostId":"2192039709","repostType":4,"repost":{"id":"2192039709","kind":"highlight","pubTimestamp":1639970366,"share":"https://www.laohu8.com/m/news/2192039709?lang=&edition=full","pubTime":"2021-12-20 11:19","market":"us","language":"en","title":"Why inflation and the U.S. policy response will be key for markets in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2192039709","media":"MarketWatch","summary":"Federal Reserve's inflation battle in 2022 will hinge on economic growth\nHow the Federal Reserve and","content":"<p>Federal Reserve's inflation battle in 2022 will hinge on economic growth</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c9ff44f1cb6fee19f2a4a8710c451c8a\" tg-width=\"700\" tg-height=\"487\" referrerpolicy=\"no-referrer\"><span>How the Federal Reserve and policy makers in Washington react to inflation pressures will be a key factor for markets in the coming year.</span></p>\n<p>U.S. financial markets have been pretty smooth sailing for investors this year, with the Federal Reserve's easy-money policies helping to iron out rough patches during the pandemic.</p>\n<p>In the final weeks of December, the S&amp;P 500 index was up 23% on the year, while U.S. \"junk bond\" yields with speculative-grade&nbsp;ratings were near historic lows around 4.5% . The broad stock market rally has made it easy to draw links between soaring asset prices and the Fed's bond buying program and heaps of fiscal aid from Washington.</p>\n<p>But that's all about to change with Fed Chairman Jerome Powell now squarely focused on keeping sharply higher costs of living from derailing the U.S. economy, and with investors expecting 2022 to be when markets really get interesting.</p>\n<p>\"I think inflation is the variable for 2022, because that's going to be what drives policy,\" said Jim Caron, senior portfolio manager at <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> Investment Management, in a phone interview Friday. \"Policy has been driving asset performance.\"</p>\n<p>And with policy something of a wild card in the coming months, particularly as the government looks to tamp down price pressures, without hamstringing the economy, Caron said he's urging investors to keep some cash on hand for buying opportunities in what could be \"a very volatile and choppy year.\"</p>\n<p><b>Inflation matters, so does growth</b></p>\n<p>U.S. stocks tumbled to their worst weekly losses in three weeks Friday, after the Fed on Wednesday outlined more aggressive plans to end its massive bond-buying program and penciled in three benchmark interest rate increases next year.</p>\n<p>Over the next few months, investors will look for the U.S. central bank to engineer a soft landing for markets as it attempts to switch gears and tighten accommodative monetary policies to fight inflation running at 1980s levels, but also keep the economy advancing.</p>\n<p>Like Europe, the U.S. also may need to balance policy with potential economic setbacks as coronavirus variants begin to drive another startling wave of winter COVID-19 infections and restrictions on consumer and business activity.</p>\n<p>\"If GDP growth disappoints and inflation remains high, it will be tough for the Fed to raise rates 75 basis points next year,\" said D.A. Davidson's James Ragan, director of wealth management research.</p>\n<p>While Fed officials increased their 2022 GDP growth forecast to 4% next year from 3.8% earlier, still above the historical trend, that's lower than the 5.5% growth expected this year. \"That type of GDP growth should support Fed rate increases and higher long-term rates,\" Ragan said, in a phone interview. Although, with the 10-year Treasury yield near 1.4%, Ragan said the bond market has been exhibiting some doubts about how much room the Fed may have to interest raise rates in the next 12 months.</p>\n<p>\"I think bond investors are still concerned about long-term growth prospects, and a little worried that three rate hikes might be a little too much,\" he said.</p>\n<p>For stocks, Ragan worries about high valuations and uncertainty about future corporate earnings, particularly if inflation slows economic activity, consumers pull back spending or wage pressures translate to lower company earnings.</p>\n<p>\"That's something to keep an eye on in early 2022,\" he said.</p>\n<p><b>'Right thing' to do</b></p>\n<p>Stephen Philipson, head of U.S. Bank's&nbsp;fixed income and capital markets group, said the Fed's more \"aggressive stance is the right thing to do to counter stubborn inflation,\" particularly with so much liquidity sloshing through financial markets during the pandemic.</p>\n<p>Philipson said he also sees looming interest rate increases as a likely catalyst for U.S. investment-grade companies&nbsp;to refinance some $1.25 trillion in debt coming due from 2023 and 2025, with coupons above 3%.</p>\n<p>\"There's a meaningful amount of debt that could be pulled forward to refinance,\" he told MarketWatch. \"We've been calling for slightly down supply for the year, but I think with the Fed taking a more aggressive approach, it could accelerate refinancing of bonds coming due over the next few years.\"</p>\n<p>The Dow Jones Industrial Average ended a volatile week 1.7% lower, while the S&amp;P 500 ended down 1.9%. The Nasdaq Composite Index tumbled 3%, with all three booking the worst week of declines since Nov. 26, according to Dow Jones Market Data.</p>\n<p>Midweek, before Friday's Christmas Eve holiday, will see a fresh slate of U.S. economic data, including December's updated consumer confidence index and existing home sales on Wednesday. But it will be Thursday with a deluge that includes weekly initial jobless claims for the week of Dec. 18, but also November updates on core inflation, personal income, consumer spending, durable goods orders and more.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why inflation and the U.S. policy response will be key for markets in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy inflation and the U.S. policy response will be key for markets in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 11:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/why-inflation-and-the-u-s-policy-response-will-be-key-for-markets-in-2022-11639795830?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Federal Reserve's inflation battle in 2022 will hinge on economic growth\nHow the Federal Reserve and policy makers in Washington react to inflation pressures will be a key factor for markets in the ...</p>\n\n<a href=\"https://www.marketwatch.com/story/why-inflation-and-the-u-s-policy-response-will-be-key-for-markets-in-2022-11639795830?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4207":"综合性银行",".SPX":"S&P 500 Index","USB":"美国合众银行",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","BK4504":"桥水持仓","BK4550":"红杉资本持仓","BK4561":"索罗斯持仓","BK4559":"巴菲特持仓"},"source_url":"https://www.marketwatch.com/story/why-inflation-and-the-u-s-policy-response-will-be-key-for-markets-in-2022-11639795830?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192039709","content_text":"Federal Reserve's inflation battle in 2022 will hinge on economic growth\nHow the Federal Reserve and policy makers in Washington react to inflation pressures will be a key factor for markets in the coming year.\nU.S. financial markets have been pretty smooth sailing for investors this year, with the Federal Reserve's easy-money policies helping to iron out rough patches during the pandemic.\nIn the final weeks of December, the S&P 500 index was up 23% on the year, while U.S. \"junk bond\" yields with speculative-grade ratings were near historic lows around 4.5% . The broad stock market rally has made it easy to draw links between soaring asset prices and the Fed's bond buying program and heaps of fiscal aid from Washington.\nBut that's all about to change with Fed Chairman Jerome Powell now squarely focused on keeping sharply higher costs of living from derailing the U.S. economy, and with investors expecting 2022 to be when markets really get interesting.\n\"I think inflation is the variable for 2022, because that's going to be what drives policy,\" said Jim Caron, senior portfolio manager at Morgan Stanley Investment Management, in a phone interview Friday. \"Policy has been driving asset performance.\"\nAnd with policy something of a wild card in the coming months, particularly as the government looks to tamp down price pressures, without hamstringing the economy, Caron said he's urging investors to keep some cash on hand for buying opportunities in what could be \"a very volatile and choppy year.\"\nInflation matters, so does growth\nU.S. stocks tumbled to their worst weekly losses in three weeks Friday, after the Fed on Wednesday outlined more aggressive plans to end its massive bond-buying program and penciled in three benchmark interest rate increases next year.\nOver the next few months, investors will look for the U.S. central bank to engineer a soft landing for markets as it attempts to switch gears and tighten accommodative monetary policies to fight inflation running at 1980s levels, but also keep the economy advancing.\nLike Europe, the U.S. also may need to balance policy with potential economic setbacks as coronavirus variants begin to drive another startling wave of winter COVID-19 infections and restrictions on consumer and business activity.\n\"If GDP growth disappoints and inflation remains high, it will be tough for the Fed to raise rates 75 basis points next year,\" said D.A. Davidson's James Ragan, director of wealth management research.\nWhile Fed officials increased their 2022 GDP growth forecast to 4% next year from 3.8% earlier, still above the historical trend, that's lower than the 5.5% growth expected this year. \"That type of GDP growth should support Fed rate increases and higher long-term rates,\" Ragan said, in a phone interview. Although, with the 10-year Treasury yield near 1.4%, Ragan said the bond market has been exhibiting some doubts about how much room the Fed may have to interest raise rates in the next 12 months.\n\"I think bond investors are still concerned about long-term growth prospects, and a little worried that three rate hikes might be a little too much,\" he said.\nFor stocks, Ragan worries about high valuations and uncertainty about future corporate earnings, particularly if inflation slows economic activity, consumers pull back spending or wage pressures translate to lower company earnings.\n\"That's something to keep an eye on in early 2022,\" he said.\n'Right thing' to do\nStephen Philipson, head of U.S. Bank's fixed income and capital markets group, said the Fed's more \"aggressive stance is the right thing to do to counter stubborn inflation,\" particularly with so much liquidity sloshing through financial markets during the pandemic.\nPhilipson said he also sees looming interest rate increases as a likely catalyst for U.S. investment-grade companies to refinance some $1.25 trillion in debt coming due from 2023 and 2025, with coupons above 3%.\n\"There's a meaningful amount of debt that could be pulled forward to refinance,\" he told MarketWatch. \"We've been calling for slightly down supply for the year, but I think with the Fed taking a more aggressive approach, it could accelerate refinancing of bonds coming due over the next few years.\"\nThe Dow Jones Industrial Average ended a volatile week 1.7% lower, while the S&P 500 ended down 1.9%. The Nasdaq Composite Index tumbled 3%, with all three booking the worst week of declines since Nov. 26, according to Dow Jones Market Data.\nMidweek, before Friday's Christmas Eve holiday, will see a fresh slate of U.S. economic data, including December's updated consumer confidence index and existing home sales on Wednesday. But it will be Thursday with a deluge that includes weekly initial jobless claims for the week of Dec. 18, but also November updates on core inflation, personal income, consumer spending, durable goods orders and more.","news_type":1},"isVote":1,"tweetType":1,"viewCount":773,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690054256,"gmtCreate":1639616278800,"gmtModify":1639616278800,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"✌️✌️✌️","listText":"✌️✌️✌️","text":"✌️✌️✌️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690054256","repostId":"1192225285","repostType":2,"isVote":1,"tweetType":1,"viewCount":708,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693386387,"gmtCreate":1639971218175,"gmtModify":1639971218241,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693386387","repostId":"1155306648","repostType":4,"isVote":1,"tweetType":1,"viewCount":775,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602401104,"gmtCreate":1639051088022,"gmtModify":1639051227812,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"😲😲😲","listText":"😲😲😲","text":"😲😲😲","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602401104","repostId":"2190503698","repostType":4,"repost":{"id":"2190503698","kind":"highlight","pubTimestamp":1639038865,"share":"https://www.laohu8.com/m/news/2190503698?lang=&edition=full","pubTime":"2021-12-09 16:34","market":"us","language":"en","title":"'Proceed with caution': here's what Wall Street analysts see for the U.S. stock market in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2190503698","media":"MarketWatch","summary":"'2022 will be a critical year when the imbalances wrought by the global pandemic begin to resolve an","content":"<p>'2022 will be a critical year when the imbalances wrought by the global pandemic begin to resolve and the business cycle normalizes from extremes,' says <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>'s Lisa Shalett</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/71e96005daaaf18cef4eb11fc31ef1c7\" tg-width=\"700\" tg-height=\"487\" referrerpolicy=\"no-referrer\"><span>‘Marginally tighter monetary policy’ should be a headwind for markets in 2022, JPMorgan strategists say</span></p>\n<p>The recent spike in market volatility may herald a bumpier U.S. stock market in 2022, as investors come to grips with an inflection point in monetary policy in the pandemic.</p>\n<p>\"There probably will be some elevated volatility around the potential tightening of Fed policy,\" said Shawn Snyder, head of investment strategy at Citigroup's U.S. consumer wealth management division, in a phone interview. \"Omicron throws in a bit of a wrench\" to the 2022 outlook, he said of the new variant of the coronavirus, though investors have appeared encouraged by some early signs that it may be less dangerous than initially feared.</p>\n<p>The CBOE Volatility Index , or VIX, jumped in late November and remains above its 200-day moving average even after subsiding since last week, according to FactSet data. The VIX broke above 30 last week for the first time since the first quarter of 2021, the data show, amid market jitters over the emergence of omicron and the potential move by the Federal Reserve to remove some accommodation from the market faster than investors had anticipated.</p>\n<p>\"That's a big transition that creates tension for investors,\" said Lauren Goodwin, economist and director of portfolio strategy at New York Life Investment, in a phone interview. The Fed looks to be positioning for more flexibility for potential interest rate hikes next year, with increased inflationary pressure likely to mean more rate rises in 2022 than currently expected, creating more market risk, she said.</p>\n<p>Some investors worry that interest rate-sensitive growth and technology stocks would be particularly vulnerable should the Fed aggressively tighten its monetary policy through rate hikes. The S&amp;P 500 index, which has a large exposure to tech, is on track for a third straight year of strong gains after rising almost 25% in 2021 through Tuesday, according to FactSet.</p>\n<p>The U.S. stock market will probably deliver more modest gains \"accompanied by higher volatility\" next year, Jeffrey Kleintop, chief global investment strategist at Charles Schwab, told MarketWatch by phone.</p>\n<p>Goodwin said she also expects increased volatility, amid transitions that include the fading of the fiscal stimulus that provided direct support to consumers during the COVID-19 crisis and the Fed taking its \"foot off the gas\" in the economic recovery. She expects \"much lower\" stock-market returns next year compared to gains so far in 2021.</p>\n<p>\"Most of the equity upside should be realized between now\" and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest,\" JPMorgan Chase &amp; Co. strategists said in a 2022 outlook report Wednesday.</p>\n<p>Wall Street banks have been rolling out their 2022 forecasts for the S&amp;P 500, with Goldman Sachs Group and JPMorgan being among the most bullish on U.S. stocks.</p>\n<p>Goldman expects the S&amp;P 500 will end 2022 at 5,100, according to a portfolio strategy research report from the bank dated Dec. 3. Meanwhile, JPMorgan analysts predicted in a research report at the end of November that the U.S. stock benchmark will rise next year to 5,050, partly on \"robust earnings growth\" and easing supply chain woes. RBC Capital Markets has forecast the same price target as JPMorgan, while Deutsche Bank predicts the S&amp;P 500 will end next year at 5,000, according to a slide presentation from its chief investment office.</p>\n<p>Meanwhile, Citigroup set an S&amp;P 500 target of 4,900 for the end of 2022, a research report from the bank in late October shows. Coming in below that level, Barclays predicted in a U.S. equity strategy report this month that the index will finish next year at 4,800.</p>\n<p>\"Proceed with caution,\" the Barclays analysts wrote in their 2022 outlook report dated Dec. 2. \"We see limited upside for equities next year,\" they said. In their view, \"household and corporate cash hoards should support modest earnings growth but persistent supply chain woes, reversal of goods consumption to trend&nbsp;are key tail risks.\"</p>\n<p>Bank of America's analysts have a lower price target than Barclays for the S&amp;P 500 next year, with a BofA Global Research report last month showing the benchmark will end 2022 at 4,600.</p>\n<p>\"Unfortunately we see a lot of similarities between today and 2000 -- the tech bubble peak,\" said Savita Subramanian, head of equity and quant strategy at BofA, during a late November media briefing on their U.S. stock market outlook.</p>\n<p>Morgan Stanley has a more bearish outlook for next year that puts the S&amp;P 500 below the index's close Tuesday at 4,686.75. A report Monday from the bank's wealth management division shows a base-case forecast of 4,400 for the S&amp;P 500 at the end of 2022 even with an expected gain in earnings.</p>\n<p>\"We expect the S&amp;P 500 to be range-bound and volatile, and bond returns to be negative net of inflation,\" said Lisa Shalett, chief investment officer at Morgan Stanley Wealth Management, in the note. \"Fixed income should be reduced to fund greater exposure to real assets and to absolute return funds.\"</p>\n<p>The core of Morgan Stanley's \"cautious\" view on the S&amp;P 500 is based on price-to-earnings ratios typically compressing during \"a midcycle transition,\" Shalett said. She pointed to a chart in her note showing that \"median stock has traversed the midcycle transition.\"</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/641e64a82babbbd377cb43247c437118\" tg-width=\"700\" tg-height=\"397\" referrerpolicy=\"no-referrer\"><span>MORGAN STANLEY WEALTH MANAGEMENT REPORT DATED DEC. 6, 2021</span></p>\n<p>The chart shows \"the median S&amp;P 500 stock has corrected 15% from its 52-week high,\" but the index has been kept aloft by the 15 largest companies now accounting for 40% of its market capitalization, according to her note.</p>\n<p>\"While they may be great companies, we are less convinced they will all be great stocks in 2022 as financial conditions tighten, interest rates rise, employment costs increase and inflation remains challenging,\" Shalett said. \"We think profit margins for the top 15 have peaked.\"</p>\n<p>In Morgan Stanley's view, \"this suggests investors should move toward stock picking and away from passive index funds,\" her note shows.</p>\n<p>JPMorgan expects that \"international equities, emerging markets and cyclical market segments will significantly outperform,\" according to its report Wednesday.</p>\n<p>\"The reason for this is our expectation for increasing interest rates and marginally tighter monetary policy that should be a headwind for high-multiple markets such as the Nasdaq,\" the JPMorgan strategists wrote, citing the tech-laden Nasdaq Composite Index .</p>\n<p>Citi's Snyder told MarketWatch that during \"midcycle\" he likes high-quality stocks, \"dividend-growers\" and global healthcare equities. Consistent earnings growth and \"reasonable valuations\" make healthcare attractive, he said, and stock bets in the area can serve as \"a volatility dampener\" in portfolios.</p>\n<p>Immunology is one of three megatrends poised to accelerate next year as \"a range of next-gen oncological therapeutics come up for approval and enable more targeted cancer treatment,\" according to Jeff Spiegel, head of U.S. iShares megatrend and international ETFs. Shares of the iShares Genomics Immunology and Healthcare ETF&nbsp;were up about 0.2% this year based on midday trading Wednesday, FactSet data show, at last check.</p>\n<p>Two other megatrends to watch in 2022 are \"digital transformation\" intensifying through the cloud, 5G and cybersecurity, and \"automation technologies\" such as robotics and artificial intelligence, Spiegel wrote in a report this month. Automation technologies should grow \"in response to ongoing supply chain bottlenecks and wage inflation\" in the pandemic, he wrote.</p>\n<p>\"I think we'll actually be dealing with gluts next year rather than shortages,\" said Charles Schwab's Kleintop. \"That will help drive down inflation, particularly in the second half of next year, making an aggressive path of rate hikes unlikely.\"</p>\n<p>The market is expecting three rate hikes by the U.S. central bank in 2022 after Fed Chair Jerome Powell signaled last week that it may speed up the tapering of its monthly asset purchases, said Deepak Puri, Deutsche Bank's CIO for the America, during a media briefing Monday on his outlook for next year.</p>\n<p>While the Fed may become more aggressive in tapering its bond purchases, potentially completing the process in March instead of June, said Puri, he expects the Fed will still be \"dovish\" on rates next year. Puri forecasts that the Fed will raise rates just once next year, which is below consensus, he said.</p>\n<p>\"We expect two rate hikes next year,\" said New York Life Investment's Goodwin.</p>\n<p>Morgan Stanley's Shalett wrote in her 2022 outlook note that \"we see a classic reflationary rebalancing in which higher nominal and real rates reflect higher average growth and inflation rates.\" She also expects yield curves will steepen, profit margins to be squeezed by rising costs, and price-to-earnings ratios to compress in \"rate-sensitive sectors.\"</p>\n<p>\"Within the U.S., we like reopening and reflationary themes and beneficiaries of higher bond yields,\" JPMorgan said in its report Wednesday. The bank's strategists expect the yield on the 10-year Treasury note will rise to 2.25% by the end of next year, the report shows.</p>\n<p>\"Our view is that 2022 will be the year of a full global recovery, an end of the global pandemic, and a return to normal conditions we had prior to the COVID-19 outbreak,\" Marko Kolanovic, chief global markets strategist at JPMorgan, and the bank's global co-head of research Hussein Malik wrote in the report Wednesday.</p>\n<p>According to Shalett, \"on most counts, 2022 will be a critical year when the imbalances wrought by the global pandemic begin to resolve and the business cycle normalizes from extremes.\"</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>'Proceed with caution': here's what Wall Street analysts see for the U.S. stock market in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n'Proceed with caution': here's what Wall Street analysts see for the U.S. stock market in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-09 16:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/proceed-with-caution-heres-what-wall-street-analysts-see-for-the-u-s-stock-market-in-2022-11638986154?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>'2022 will be a critical year when the imbalances wrought by the global pandemic begin to resolve and the business cycle normalizes from extremes,' says Morgan Stanley's Lisa Shalett\n‘Marginally ...</p>\n\n<a href=\"https://www.marketwatch.com/story/proceed-with-caution-heres-what-wall-street-analysts-see-for-the-u-s-stock-market-in-2022-11638986154?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/proceed-with-caution-heres-what-wall-street-analysts-see-for-the-u-s-stock-market-in-2022-11638986154?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190503698","content_text":"'2022 will be a critical year when the imbalances wrought by the global pandemic begin to resolve and the business cycle normalizes from extremes,' says Morgan Stanley's Lisa Shalett\n‘Marginally tighter monetary policy’ should be a headwind for markets in 2022, JPMorgan strategists say\nThe recent spike in market volatility may herald a bumpier U.S. stock market in 2022, as investors come to grips with an inflection point in monetary policy in the pandemic.\n\"There probably will be some elevated volatility around the potential tightening of Fed policy,\" said Shawn Snyder, head of investment strategy at Citigroup's U.S. consumer wealth management division, in a phone interview. \"Omicron throws in a bit of a wrench\" to the 2022 outlook, he said of the new variant of the coronavirus, though investors have appeared encouraged by some early signs that it may be less dangerous than initially feared.\nThe CBOE Volatility Index , or VIX, jumped in late November and remains above its 200-day moving average even after subsiding since last week, according to FactSet data. The VIX broke above 30 last week for the first time since the first quarter of 2021, the data show, amid market jitters over the emergence of omicron and the potential move by the Federal Reserve to remove some accommodation from the market faster than investors had anticipated.\n\"That's a big transition that creates tension for investors,\" said Lauren Goodwin, economist and director of portfolio strategy at New York Life Investment, in a phone interview. The Fed looks to be positioning for more flexibility for potential interest rate hikes next year, with increased inflationary pressure likely to mean more rate rises in 2022 than currently expected, creating more market risk, she said.\nSome investors worry that interest rate-sensitive growth and technology stocks would be particularly vulnerable should the Fed aggressively tighten its monetary policy through rate hikes. The S&P 500 index, which has a large exposure to tech, is on track for a third straight year of strong gains after rising almost 25% in 2021 through Tuesday, according to FactSet.\nThe U.S. stock market will probably deliver more modest gains \"accompanied by higher volatility\" next year, Jeffrey Kleintop, chief global investment strategist at Charles Schwab, told MarketWatch by phone.\nGoodwin said she also expects increased volatility, amid transitions that include the fading of the fiscal stimulus that provided direct support to consumers during the COVID-19 crisis and the Fed taking its \"foot off the gas\" in the economic recovery. She expects \"much lower\" stock-market returns next year compared to gains so far in 2021.\n\"Most of the equity upside should be realized between now\" and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest,\" JPMorgan Chase & Co. strategists said in a 2022 outlook report Wednesday.\nWall Street banks have been rolling out their 2022 forecasts for the S&P 500, with Goldman Sachs Group and JPMorgan being among the most bullish on U.S. stocks.\nGoldman expects the S&P 500 will end 2022 at 5,100, according to a portfolio strategy research report from the bank dated Dec. 3. Meanwhile, JPMorgan analysts predicted in a research report at the end of November that the U.S. stock benchmark will rise next year to 5,050, partly on \"robust earnings growth\" and easing supply chain woes. RBC Capital Markets has forecast the same price target as JPMorgan, while Deutsche Bank predicts the S&P 500 will end next year at 5,000, according to a slide presentation from its chief investment office.\nMeanwhile, Citigroup set an S&P 500 target of 4,900 for the end of 2022, a research report from the bank in late October shows. Coming in below that level, Barclays predicted in a U.S. equity strategy report this month that the index will finish next year at 4,800.\n\"Proceed with caution,\" the Barclays analysts wrote in their 2022 outlook report dated Dec. 2. \"We see limited upside for equities next year,\" they said. In their view, \"household and corporate cash hoards should support modest earnings growth but persistent supply chain woes, reversal of goods consumption to trend are key tail risks.\"\nBank of America's analysts have a lower price target than Barclays for the S&P 500 next year, with a BofA Global Research report last month showing the benchmark will end 2022 at 4,600.\n\"Unfortunately we see a lot of similarities between today and 2000 -- the tech bubble peak,\" said Savita Subramanian, head of equity and quant strategy at BofA, during a late November media briefing on their U.S. stock market outlook.\nMorgan Stanley has a more bearish outlook for next year that puts the S&P 500 below the index's close Tuesday at 4,686.75. A report Monday from the bank's wealth management division shows a base-case forecast of 4,400 for the S&P 500 at the end of 2022 even with an expected gain in earnings.\n\"We expect the S&P 500 to be range-bound and volatile, and bond returns to be negative net of inflation,\" said Lisa Shalett, chief investment officer at Morgan Stanley Wealth Management, in the note. \"Fixed income should be reduced to fund greater exposure to real assets and to absolute return funds.\"\nThe core of Morgan Stanley's \"cautious\" view on the S&P 500 is based on price-to-earnings ratios typically compressing during \"a midcycle transition,\" Shalett said. She pointed to a chart in her note showing that \"median stock has traversed the midcycle transition.\"\nMORGAN STANLEY WEALTH MANAGEMENT REPORT DATED DEC. 6, 2021\nThe chart shows \"the median S&P 500 stock has corrected 15% from its 52-week high,\" but the index has been kept aloft by the 15 largest companies now accounting for 40% of its market capitalization, according to her note.\n\"While they may be great companies, we are less convinced they will all be great stocks in 2022 as financial conditions tighten, interest rates rise, employment costs increase and inflation remains challenging,\" Shalett said. \"We think profit margins for the top 15 have peaked.\"\nIn Morgan Stanley's view, \"this suggests investors should move toward stock picking and away from passive index funds,\" her note shows.\nJPMorgan expects that \"international equities, emerging markets and cyclical market segments will significantly outperform,\" according to its report Wednesday.\n\"The reason for this is our expectation for increasing interest rates and marginally tighter monetary policy that should be a headwind for high-multiple markets such as the Nasdaq,\" the JPMorgan strategists wrote, citing the tech-laden Nasdaq Composite Index .\nCiti's Snyder told MarketWatch that during \"midcycle\" he likes high-quality stocks, \"dividend-growers\" and global healthcare equities. Consistent earnings growth and \"reasonable valuations\" make healthcare attractive, he said, and stock bets in the area can serve as \"a volatility dampener\" in portfolios.\nImmunology is one of three megatrends poised to accelerate next year as \"a range of next-gen oncological therapeutics come up for approval and enable more targeted cancer treatment,\" according to Jeff Spiegel, head of U.S. iShares megatrend and international ETFs. Shares of the iShares Genomics Immunology and Healthcare ETF were up about 0.2% this year based on midday trading Wednesday, FactSet data show, at last check.\nTwo other megatrends to watch in 2022 are \"digital transformation\" intensifying through the cloud, 5G and cybersecurity, and \"automation technologies\" such as robotics and artificial intelligence, Spiegel wrote in a report this month. Automation technologies should grow \"in response to ongoing supply chain bottlenecks and wage inflation\" in the pandemic, he wrote.\n\"I think we'll actually be dealing with gluts next year rather than shortages,\" said Charles Schwab's Kleintop. \"That will help drive down inflation, particularly in the second half of next year, making an aggressive path of rate hikes unlikely.\"\nThe market is expecting three rate hikes by the U.S. central bank in 2022 after Fed Chair Jerome Powell signaled last week that it may speed up the tapering of its monthly asset purchases, said Deepak Puri, Deutsche Bank's CIO for the America, during a media briefing Monday on his outlook for next year.\nWhile the Fed may become more aggressive in tapering its bond purchases, potentially completing the process in March instead of June, said Puri, he expects the Fed will still be \"dovish\" on rates next year. Puri forecasts that the Fed will raise rates just once next year, which is below consensus, he said.\n\"We expect two rate hikes next year,\" said New York Life Investment's Goodwin.\nMorgan Stanley's Shalett wrote in her 2022 outlook note that \"we see a classic reflationary rebalancing in which higher nominal and real rates reflect higher average growth and inflation rates.\" She also expects yield curves will steepen, profit margins to be squeezed by rising costs, and price-to-earnings ratios to compress in \"rate-sensitive sectors.\"\n\"Within the U.S., we like reopening and reflationary themes and beneficiaries of higher bond yields,\" JPMorgan said in its report Wednesday. The bank's strategists expect the yield on the 10-year Treasury note will rise to 2.25% by the end of next year, the report shows.\n\"Our view is that 2022 will be the year of a full global recovery, an end of the global pandemic, and a return to normal conditions we had prior to the COVID-19 outbreak,\" Marko Kolanovic, chief global markets strategist at JPMorgan, and the bank's global co-head of research Hussein Malik wrote in the report Wednesday.\nAccording to Shalett, \"on most counts, 2022 will be a critical year when the imbalances wrought by the global pandemic begin to resolve and the business cycle normalizes from extremes.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":612,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":630345015,"gmtCreate":1642725433815,"gmtModify":1642725441780,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"OK👌","listText":"OK👌","text":"OK👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/630345015","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","kind":"news","pubTimestamp":1641612579,"share":"https://www.laohu8.com/m/news/1134509683?lang=&edition=full","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<html><head></head><body><p>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>A safe harbor in stormy weather</b></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><b>The antibody market all to itself</b></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc.","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1056,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":630342483,"gmtCreate":1642725393521,"gmtModify":1642725393632,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"OK👌","listText":"OK👌","text":"OK👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/630342483","repostId":"1138592368","repostType":4,"repost":{"id":"1138592368","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641997842,"share":"https://www.laohu8.com/m/news/1138592368?lang=&edition=full","pubTime":"2022-01-12 22:30","market":"us","language":"en","title":"Stocks rise as Wall Street shakes off red hot inflation report","url":"https://stock-news.laohu8.com/highlight/detail?id=1138592368","media":"Tiger Newspress","summary":"Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high","content":"<html><head></head><body><p>Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high rate of price increases across the recovering economy. Still, this came a day following remarks from Federal Reserve Chair Jerome Powell reasserting that the central bank would step in as needed to rein in rising prices.</p><p>The Bureau of Labor Statistics&#39; December Consumer Price Index (CPI)showed prices rose at a 7.0% year-over-year rate at the end of 2021, marking the fastest increase since 1982. This matched consensus estimates, based on Bloomberg data, and accelerated from November&#39;s already elevated 6.8% increase. On a month-over-month basis, consumer prices rose 0.5%, or slightly more than the 0.4% rise expected, to mark an eighteenth consecutive month of prices increases.</p><p>Excluding food and energy prices, the so-called core measure of consumer prices rose 5.5% in December over last year, coming in at the fastest rate since 1991.</p><p>Wednesday&#39;s market moves came following a rebound rally on Tuesday, with markets at least temporarily finding relief in assurances from Federal Reserve Chair Jerome Powell that the central bank would step in as necessary to ease rising prices. InPowell&#39;s renomination hearing before the Senate Banking Committee, the central bank leader reiterated that the Fed would use its policy tools to bring down inflation.</p><p>“If we see inflation persisting at high levels, longer than expected, if we have to raise interest rates more over time, then we will,” Powell said during the hearing.</p><p>The central bankpreviously telegraphed it was eyeing three interest rate hikesthis year to bring benchmark rates up from their current near-zero levels. However, some topWall Street firms have predictedthe Fed will raise rates four times given the current inflationary backdrop.</p><p>But though Powell doubled down on the Fed&#39;s goal of curbing inflation and using interest rate hikes as a tool to achieve this, he revealed little further about the Fed&#39;s plan to begin shrinking its nearly $9 trillion balance sheet. The Fed&#39;s December meeting minutes last week suggested central bank officials were beginning to discuss drawing down the Fed&#39;s balance sheet after nearly two years of asset purchases to help support markets during the pandemic. Powell did reiterate in his hearing he expected the balance sheet runoff process would begin this year.</p><p>&#34;I think the biggest comment on most investors&#39; minds that we talk to around the world would be a &#39;policy mistake&#39; that the Fed might be too aggressive,&#34; Brian Belski, BMO Capital Markets chief investment strategist,told Yahoo Finance Live on Tuesday.&#34;Mr. Powell basically came out today and said this is going to be a process ... with respect to how long this is going to take, and I think that&#39;s what&#39;s calming investors.&#34;</p><p>Though prospects of higher borrowing costs and tighter financial conditions have stirred up volatility in U.S. equities and tech stocks especially in recent sessions, Tuesday&#39;s session saw a reversal, with the tech-heavy Nasdaq Composite sharply outperforming.</p><p>&#34;The issue with tech, I would argue, is not so much one of a little extra duration exposure because growth is further away, but it&#39;s simply one of valuation,&#34; Simeon Hyman, ProShares Global Investment Strategist,told Yahoo Finance Live on Tuesday.&#34;And indeed those top-heavy, largest-cap tech stocks perhaps just were a little bit expensive going into the end of last year and the beginning of 2022. But don&#39;t completely rule out good growth stories because that is the biggest defense against inflation. It is the growth of earnings and dividends.&#34;</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks rise as Wall Street shakes off red hot inflation report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks rise as Wall Street shakes off red hot inflation report\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-12 22:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high rate of price increases across the recovering economy. Still, this came a day following remarks from Federal Reserve Chair Jerome Powell reasserting that the central bank would step in as needed to rein in rising prices.</p><p>The Bureau of Labor Statistics&#39; December Consumer Price Index (CPI)showed prices rose at a 7.0% year-over-year rate at the end of 2021, marking the fastest increase since 1982. This matched consensus estimates, based on Bloomberg data, and accelerated from November&#39;s already elevated 6.8% increase. On a month-over-month basis, consumer prices rose 0.5%, or slightly more than the 0.4% rise expected, to mark an eighteenth consecutive month of prices increases.</p><p>Excluding food and energy prices, the so-called core measure of consumer prices rose 5.5% in December over last year, coming in at the fastest rate since 1991.</p><p>Wednesday&#39;s market moves came following a rebound rally on Tuesday, with markets at least temporarily finding relief in assurances from Federal Reserve Chair Jerome Powell that the central bank would step in as necessary to ease rising prices. InPowell&#39;s renomination hearing before the Senate Banking Committee, the central bank leader reiterated that the Fed would use its policy tools to bring down inflation.</p><p>“If we see inflation persisting at high levels, longer than expected, if we have to raise interest rates more over time, then we will,” Powell said during the hearing.</p><p>The central bankpreviously telegraphed it was eyeing three interest rate hikesthis year to bring benchmark rates up from their current near-zero levels. However, some topWall Street firms have predictedthe Fed will raise rates four times given the current inflationary backdrop.</p><p>But though Powell doubled down on the Fed&#39;s goal of curbing inflation and using interest rate hikes as a tool to achieve this, he revealed little further about the Fed&#39;s plan to begin shrinking its nearly $9 trillion balance sheet. The Fed&#39;s December meeting minutes last week suggested central bank officials were beginning to discuss drawing down the Fed&#39;s balance sheet after nearly two years of asset purchases to help support markets during the pandemic. Powell did reiterate in his hearing he expected the balance sheet runoff process would begin this year.</p><p>&#34;I think the biggest comment on most investors&#39; minds that we talk to around the world would be a &#39;policy mistake&#39; that the Fed might be too aggressive,&#34; Brian Belski, BMO Capital Markets chief investment strategist,told Yahoo Finance Live on Tuesday.&#34;Mr. Powell basically came out today and said this is going to be a process ... with respect to how long this is going to take, and I think that&#39;s what&#39;s calming investors.&#34;</p><p>Though prospects of higher borrowing costs and tighter financial conditions have stirred up volatility in U.S. equities and tech stocks especially in recent sessions, Tuesday&#39;s session saw a reversal, with the tech-heavy Nasdaq Composite sharply outperforming.</p><p>&#34;The issue with tech, I would argue, is not so much one of a little extra duration exposure because growth is further away, but it&#39;s simply one of valuation,&#34; Simeon Hyman, ProShares Global Investment Strategist,told Yahoo Finance Live on Tuesday.&#34;And indeed those top-heavy, largest-cap tech stocks perhaps just were a little bit expensive going into the end of last year and the beginning of 2022. But don&#39;t completely rule out good growth stories because that is the biggest defense against inflation. It is the growth of earnings and dividends.&#34;</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138592368","content_text":"Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high rate of price increases across the recovering economy. Still, this came a day following remarks from Federal Reserve Chair Jerome Powell reasserting that the central bank would step in as needed to rein in rising prices.The Bureau of Labor Statistics' December Consumer Price Index (CPI)showed prices rose at a 7.0% year-over-year rate at the end of 2021, marking the fastest increase since 1982. This matched consensus estimates, based on Bloomberg data, and accelerated from November's already elevated 6.8% increase. On a month-over-month basis, consumer prices rose 0.5%, or slightly more than the 0.4% rise expected, to mark an eighteenth consecutive month of prices increases.Excluding food and energy prices, the so-called core measure of consumer prices rose 5.5% in December over last year, coming in at the fastest rate since 1991.Wednesday's market moves came following a rebound rally on Tuesday, with markets at least temporarily finding relief in assurances from Federal Reserve Chair Jerome Powell that the central bank would step in as necessary to ease rising prices. InPowell's renomination hearing before the Senate Banking Committee, the central bank leader reiterated that the Fed would use its policy tools to bring down inflation.“If we see inflation persisting at high levels, longer than expected, if we have to raise interest rates more over time, then we will,” Powell said during the hearing.The central bankpreviously telegraphed it was eyeing three interest rate hikesthis year to bring benchmark rates up from their current near-zero levels. However, some topWall Street firms have predictedthe Fed will raise rates four times given the current inflationary backdrop.But though Powell doubled down on the Fed's goal of curbing inflation and using interest rate hikes as a tool to achieve this, he revealed little further about the Fed's plan to begin shrinking its nearly $9 trillion balance sheet. The Fed's December meeting minutes last week suggested central bank officials were beginning to discuss drawing down the Fed's balance sheet after nearly two years of asset purchases to help support markets during the pandemic. Powell did reiterate in his hearing he expected the balance sheet runoff process would begin this year.\"I think the biggest comment on most investors' minds that we talk to around the world would be a 'policy mistake' that the Fed might be too aggressive,\" Brian Belski, BMO Capital Markets chief investment strategist,told Yahoo Finance Live on Tuesday.\"Mr. Powell basically came out today and said this is going to be a process ... with respect to how long this is going to take, and I think that's what's calming investors.\"Though prospects of higher borrowing costs and tighter financial conditions have stirred up volatility in U.S. equities and tech stocks especially in recent sessions, Tuesday's session saw a reversal, with the tech-heavy Nasdaq Composite sharply outperforming.\"The issue with tech, I would argue, is not so much one of a little extra duration exposure because growth is further away, but it's simply one of valuation,\" Simeon Hyman, ProShares Global Investment Strategist,told Yahoo Finance Live on Tuesday.\"And indeed those top-heavy, largest-cap tech stocks perhaps just were a little bit expensive going into the end of last year and the beginning of 2022. But don't completely rule out good growth stories because that is the biggest defense against inflation. It is the growth of earnings and dividends.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":1022,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698820820,"gmtCreate":1640343733999,"gmtModify":1640344031317,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"Okokok good idea","listText":"Okokok good idea","text":"Okokok good idea","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698820820","isVote":1,"tweetType":1,"viewCount":1107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690428907,"gmtCreate":1639703201782,"gmtModify":1639703201846,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"Notes","listText":"Notes","text":"Notes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690428907","repostId":"2192947044","repostType":4,"repost":{"id":"2192947044","kind":"highlight","pubTimestamp":1639699547,"share":"https://www.laohu8.com/m/news/2192947044?lang=&edition=full","pubTime":"2021-12-17 08:05","market":"us","language":"en","title":"Oracle in talks to buy Cerner","url":"https://stock-news.laohu8.com/highlight/detail?id=2192947044","media":"The Wall Street Journal","summary":"Oracle Corp. ORCL -0.41% is in talks to buy electronic-medical-records company Cerner Corp. CERN 0.7","content":"<p>Oracle Corp. ORCL -0.41% is in talks to buy electronic-medical-records company Cerner Corp. CERN 0.72% , according to people familiar with the matter, a deal that could be worth around $30 billion and push the enterprise-software giant further into healthcare.</p>\n<p></p>\n<p>An agreement could be finalized soon, some of the people said, assuming the talks don’t fall apart or drag out. Should a deal come together, it would rank as the biggest ever for Oracle, which has a market value of more than $280 billion.</p>\n<p></p>\n<p>Kansas City, Mo.-based Cerner designs software that hospitals and doctors use to store and analyze medical records and other healthcare data. It has a market value of around $23 billion. With a typical takeover premium, a deal would be expected to value the company at something like $30 billion, though exact terms being discussed couldn’t be learned.</p>\n<p></p>\n<p>Oracle, a Silicon Valley veteran that last year moved its headquarters to Austin, Texas, is one of the biggest software providers to other companies and organizations.</p>\n<p>In August, Cerner tapped David Feinberg as chief executive officer, a role he assumed in October. Mr. Feinberg came from Oracle rival Google, where he had led the Alphabet Inc. unit’s push into healthcare and helped strike partnerships with some of the country’s largest hospital systems to collect and analyze their data.</p>\n<p></p>\n<p>Oracle already has a significant presence in healthcare, offering technology meant to help health insurers, healthcare providers and public health systems parse data to increase efficiency and improve patient outcomes.</p>\n<p></p>\n<p></p>\n<p>Oracle shares closed Thursday at $103.22, down slightly amid a broad-based tech selloff and just off an all-time high reached the day before. They jumped over 15% last week when the company reported fiscal-second-quarter results that topped estimates and Chief Executive Safra Catz reiterated the expectation that full-year revenue growth would accelerate from the year earlier. Ms. Catz, who became the sole CEO in 2019, said she expects the company’s operating margins to be the same or better than they were pre-pandemic.</p>\n<p></p>\n<p>The company also increased the authorization for share repurchases by $10 billion.</p>\n<p></p>\n<p>Buying Cerner could help Oracle with its pivot toward the cloud. Investors have warmed to Oracle as the company ramps up its focus on winning cloud-computing business, after initially being slow to embrace the booming market for storing and analyzing data on remote servers. Oracle has been trying to make up ground in recent years after falling behind companies such as Amazon.com Inc. and Microsoft Corp. , which both now have market values well exceeding $1 trillion thanks in part to thriving cloud units.</p>\n<p></p>\n<p>A deal for Cerner would follow Microsoft’s agreement in April to buy artificial-intelligence company Nuance Communications Inc. for $16 billion, in a bet on the growing demand for digital healthcare tools.</p>\n<p></p>\n<p>Oracle was founded by outspoken billionaire Larry Ellison and others in 1977. Mr. Ellison owns roughly 42% of the company’s shares, a stake that is worth well over $100 billion. Mr. Ellison passed the CEO reins to Ms. Catz and the late Mark Hurd in 2014, but remains chairman and chief technology officer.</p>\n<p></p>\n<p>A deal for Cerner would easily top Oracle’s next-largest transaction, the roughly $10 billion purchase of enterprise-software firm PeopleSoft Inc. that closed in 2005, followed by a $9 billion deal for cloud-software provider NetSuite Inc. in 2016.</p>\n<p></p>\n<p>In 2020, Oracle showed an appetite for bigger deals when it beat out Microsoft in bidding for the video-sharing app TikTok’s U.S. operations. The Trump administration’s concerns about TikTok’s Chinese ownership had effectively put the business in play, but the deal was put on hold indefinitely by the Biden administration.</p>\n<p></p>\n<p>Cerner, founded in 1979, competes with the likes of privately held Epic Systems Corp. and Athenahealth Inc., which recently agreed to a sale to one group of private-equity firms by another for around $17 billion including debt.</p>\n<p></p>\n<p>Cerner shares rose slightly to $79.49 Thursday.</p>\n<p></p>\n<p></p>\n<p>An Oracle-Cerner deal would rank as one of the largest takeovers of 2021, which is shaping up to be one of the busiest ever for mergers and acquisitions. Merger activity in the U.S. is up 78% to $2.45 trillion, according to Dealogic, as lofty stock prices and easy money embolden companies to strike deals and special-purpose acquisition companies are formed at a breakneck pace.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oracle in talks to buy Cerner</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOracle in talks to buy Cerner\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 08:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/oracle-in-talks-to-buy-cerner-11639697730?mod=hp_lead_pos2><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Oracle Corp. ORCL -0.41% is in talks to buy electronic-medical-records company Cerner Corp. CERN 0.72% , according to people familiar with the matter, a deal that could be worth around $30 billion and...</p>\n\n<a href=\"https://www.wsj.com/articles/oracle-in-talks-to-buy-cerner-11639697730?mod=hp_lead_pos2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4167":"医疗保健技术","CERN":"美国塞纳","ORCL":"甲骨文","BK4538":"云计算","BK4534":"瑞士信贷持仓","BK4097":"系统软件","BK4528":"SaaS概念","BK4516":"特朗普概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4504":"桥水持仓"},"source_url":"https://www.wsj.com/articles/oracle-in-talks-to-buy-cerner-11639697730?mod=hp_lead_pos2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192947044","content_text":"Oracle Corp. ORCL -0.41% is in talks to buy electronic-medical-records company Cerner Corp. CERN 0.72% , according to people familiar with the matter, a deal that could be worth around $30 billion and push the enterprise-software giant further into healthcare.\n\nAn agreement could be finalized soon, some of the people said, assuming the talks don’t fall apart or drag out. Should a deal come together, it would rank as the biggest ever for Oracle, which has a market value of more than $280 billion.\n\nKansas City, Mo.-based Cerner designs software that hospitals and doctors use to store and analyze medical records and other healthcare data. It has a market value of around $23 billion. With a typical takeover premium, a deal would be expected to value the company at something like $30 billion, though exact terms being discussed couldn’t be learned.\n\nOracle, a Silicon Valley veteran that last year moved its headquarters to Austin, Texas, is one of the biggest software providers to other companies and organizations.\nIn August, Cerner tapped David Feinberg as chief executive officer, a role he assumed in October. Mr. Feinberg came from Oracle rival Google, where he had led the Alphabet Inc. unit’s push into healthcare and helped strike partnerships with some of the country’s largest hospital systems to collect and analyze their data.\n\nOracle already has a significant presence in healthcare, offering technology meant to help health insurers, healthcare providers and public health systems parse data to increase efficiency and improve patient outcomes.\n\n\nOracle shares closed Thursday at $103.22, down slightly amid a broad-based tech selloff and just off an all-time high reached the day before. They jumped over 15% last week when the company reported fiscal-second-quarter results that topped estimates and Chief Executive Safra Catz reiterated the expectation that full-year revenue growth would accelerate from the year earlier. Ms. Catz, who became the sole CEO in 2019, said she expects the company’s operating margins to be the same or better than they were pre-pandemic.\n\nThe company also increased the authorization for share repurchases by $10 billion.\n\nBuying Cerner could help Oracle with its pivot toward the cloud. Investors have warmed to Oracle as the company ramps up its focus on winning cloud-computing business, after initially being slow to embrace the booming market for storing and analyzing data on remote servers. Oracle has been trying to make up ground in recent years after falling behind companies such as Amazon.com Inc. and Microsoft Corp. , which both now have market values well exceeding $1 trillion thanks in part to thriving cloud units.\n\nA deal for Cerner would follow Microsoft’s agreement in April to buy artificial-intelligence company Nuance Communications Inc. for $16 billion, in a bet on the growing demand for digital healthcare tools.\n\nOracle was founded by outspoken billionaire Larry Ellison and others in 1977. Mr. Ellison owns roughly 42% of the company’s shares, a stake that is worth well over $100 billion. Mr. Ellison passed the CEO reins to Ms. Catz and the late Mark Hurd in 2014, but remains chairman and chief technology officer.\n\nA deal for Cerner would easily top Oracle’s next-largest transaction, the roughly $10 billion purchase of enterprise-software firm PeopleSoft Inc. that closed in 2005, followed by a $9 billion deal for cloud-software provider NetSuite Inc. in 2016.\n\nIn 2020, Oracle showed an appetite for bigger deals when it beat out Microsoft in bidding for the video-sharing app TikTok’s U.S. operations. The Trump administration’s concerns about TikTok’s Chinese ownership had effectively put the business in play, but the deal was put on hold indefinitely by the Biden administration.\n\nCerner, founded in 1979, competes with the likes of privately held Epic Systems Corp. and Athenahealth Inc., which recently agreed to a sale to one group of private-equity firms by another for around $17 billion including debt.\n\nCerner shares rose slightly to $79.49 Thursday.\n\n\nAn Oracle-Cerner deal would rank as one of the largest takeovers of 2021, which is shaping up to be one of the busiest ever for mergers and acquisitions. Merger activity in the U.S. is up 78% to $2.45 trillion, according to Dealogic, as lofty stock prices and easy money embolden companies to strike deals and special-purpose acquisition companies are formed at a breakneck pace.","news_type":1},"isVote":1,"tweetType":1,"viewCount":469,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697404839,"gmtCreate":1642551869823,"gmtModify":1642551870152,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"Ok👌","listText":"Ok👌","text":"Ok👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697404839","repostId":"2204841800","repostType":2,"repost":{"id":"2204841800","kind":"news","pubTimestamp":1642541820,"share":"https://www.laohu8.com/m/news/2204841800?lang=&edition=full","pubTime":"2022-01-19 05:37","market":"us","language":"zh","title":"外媒头条：一次加息50个基点！市场预期越发激进","url":"https://stock-news.laohu8.com/highlight/detail?id=2204841800","media":"新浪财经","summary":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：1、货币市场预计美联储或一次升息50基点 将是2020年以来最大动作2、微软发起其史上最大规模收购 以近690亿美元收购动视暴雪3、贝莱德CEO：美联储“","content":"<html><head></head><body><p><b>全球财经媒体昨夜今晨共同关注的头条新闻主要有：</b></p><blockquote><b>1、货币市场预计美联储或一次升息50基点 将是2020年以来最大动作</b></blockquote><blockquote><b>2、<a href=\"https://laohu8.com/S/MSFT\">微软</a>发起其史上最大规模收购 以近690亿美元收购<a href=\"https://laohu8.com/S/ATVI\">动视暴雪</a></b></blockquote><blockquote><b>3、<a href=\"https://laohu8.com/S/BLK\">贝莱德</a>CEO：美联储“激进”立场或导致收益率曲线趋平</b></blockquote><blockquote><b>4、原油飙升至2014年以来高点 拜登政府称正继续与产油国合作</b></blockquote><blockquote><b>5、研究显示omicron感染浪潮可能降低疫情未来的严重程度</b></blockquote><blockquote><b>6、2021年<a href=\"https://laohu8.com/S/AAPL\">苹果</a>手机占全球智能手机出货量22% 位居第一</b></blockquote><p><img src=\"https://static.tigerbbs.com/698315ff48290ccd4244f61fe7019f2b\" tg-width=\"550\" tg-height=\"369\" referrerpolicy=\"no-referrer\"/></p><p><b>货币市场预计美联储或一次升息50基点 将是2020年以来最大动作</b></p><p>货币市场价格显示，越来越多投资者预期美联储可能逾二十年来首次大规模提高借贷成本。</p><p>虽然加息25个基点仍是最有可能的情形，但掉期市场现在预计3月底前加息幅度将超过25个基点。鉴于本月政策会议预计不会有任何行动，这表明交易员至少正在考虑3月加息50个基点的可能性。自2000年5月以来， 美联储还从没有一口气加息这么多过。</p><p>近日来围绕美联储更大幅加息的猜测升温可能加剧了周二美国国债跌势。 <a href=\"https://laohu8.com/S/JPM\">摩根大通</a>首席执行官杰米·戴蒙上周警告美联储收紧政策可能不会像一些人预期的那样“和风细雨”，亿万富翁投资者Bill Ackman表示美联储应该在3月加息50个基点，以重建公信力。</p><p>CFTC最新持仓数据显示，对冲基金将净欧洲美元空头头寸提高至2018年12月以来最大水平，投机者对10年期国债期货的看空程度也达到2020年2月以来最高。</p><p><img src=\"https://static.tigerbbs.com/d7cad28562d81d8fed2fe8d732aa7112\" tg-width=\"550\" tg-height=\"296\" referrerpolicy=\"no-referrer\"/></p><p><b><a href=\"https://laohu8.com/S/MSFT\">微软</a>发起其史上最大规模收购 以近690亿美元收购<a href=\"https://laohu8.com/S/ATVI\">动视暴雪</a></b></p><p>微软宣布以687亿美元收购动视暴雪，促成视频游戏领域的两大巨头强强联合。</p><p>作为微软有史以来进行的最大一笔收购，该交易对这家美国最大游戏发行商之一的收购价为每股95美元现金。微软称，动视暴雪首席执行官Bobby Kotick将继续担任当前职位。交易完成后，动视暴雪业务将汇报给微软游戏部门负责人Phil Spencer。</p><p>交易完成后，微软将成为按营收计算的全球第三大游戏公司，仅次于<a href=\"https://laohu8.com/S/00700\">腾讯</a>和<a href=\"https://laohu8.com/S/SNE\">索尼</a>。</p><p>将动视暴雪热门游戏收入囊中，将有助于微软扩大其Xbox游戏机内容，提高对<a href=\"https://laohu8.com/S/SONY\">索尼</a>PlayStation的竞争力。动视暴雪与Xbox的合作由来已久。这家发行商最大一款游戏《使命召唤》的成功，很大程度上是得益于微软创新性的在线平台Xbox Live，该平台允许玩家联机进行多人对战。动视暴雪大多数游戏都在Xbox游戏机上发布。</p><p><img src=\"https://static.tigerbbs.com/733e77ab67cbbd3d5818c24cbcb9916a\" tg-width=\"550\" tg-height=\"366\" referrerpolicy=\"no-referrer\"/></p><p><b><a href=\"https://laohu8.com/S/BLK\">贝莱德</a>CEO：美联储“激进”立场或导致收益率曲线趋平</b></p><p>全球最大资产管理公司贝莱德CEO Larry Fink表示，美联储快速调整货币政策以遏制通胀可能会导致美国国债收益率曲线趋于平缓。</p><p>“我认为收益率曲线将会变平，如果美联储非常激进，我甚至可以看到一条负的收益率曲线，”Fink周二表示。</p><p>收益率曲线的形状揭示了投资者对美国经济增长和货币政策的预期。美联储计划早于预期加息的鹰派立场推高了短期利率，使曲线变平。</p><p>分析师通常认为，短期美国国债收益率与较长期美债收益率之差缩小（即收益率曲线趋平），是对经济增长和货币政策不确定性的担忧迹象。负的收益率曲线或曲线倒挂通常预示着经济衰退。</p><p>“收益率曲线的形状将成为决定经济的关键问题，”Fink说。</p><p><img src=\"https://static.tigerbbs.com/894b2f0869773330f31bbaf4cb56d3ec\" tg-width=\"550\" tg-height=\"365\" referrerpolicy=\"no-referrer\"/></p><p><b>原油飙升至2014年以来高点 拜登政府称正继续与产油国合作</b></p><p>油价升至七年高点之际，白宫称拜登政府正在与产油国合作，将确保供应达到足以满足需求的水平。</p><p>美国国家安全委员会发言人Emily Horne周二在一份声明中表示，白宫计划继续在全球经济增长的背景下监控能源价格，必要时会与OPEC+国家举行磋商。</p><p>Horne称，“我们会继续与产油国和消费国合作，这些措施已经对价格产生了实际影响，我们仍然保留可解决能源价格问题的工具” 。</p><p>汽油价格上涨一直是导致拜登任期内通胀飙升的主要因素，白宫千方百计降低汽油成本。油价上涨正在损害拜登的支持率，民主党在11月中期选举中保住两院多数党地位的难度加大。</p><p><img src=\"https://static.tigerbbs.com/504a7eb8073637bdb53e621b0dd905d0\" tg-width=\"550\" tg-height=\"343\" referrerpolicy=\"no-referrer\"/></p><p><b>研究显示omicron感染浪潮可能降低疫情未来的严重程度</b></p><p>南非的研究人员表示，虽然omicron变种病毒引发一轮强烈的新冠疫情浪潮，但却可能会加速大流行病所造成各种干扰的终结，因为感染omicron的症状似乎较轻，并能提供针对德尔塔变种病毒的保护。</p><p>南非一个实验室将去年11月和12月感染omicron的23人作为样本进行的研究显示，虽然先前感染了德尔塔毒株的人可以感染omicron，但感染omicron株的人不会再感染德尔塔。</p><p>尽管omicron的感染力明显高于德尔塔，但包括南非在内的一些国家的医院和死亡率数据似乎表明，它导致的疾病严重程度较低。南非是最早出现omicron感染浪潮的国家。南非卫生研究所Alex Sigal等人的这项研究显示，omicron可以取代德尔塔毒株。</p><p>“这种取代的影响将取决于omicron的致病性是否确实低于德尔塔，”研究人员说。 “如果的确如此，那么Covid-19重症的发生率将降低，疫情对个人和社会的破坏性将会减弱。”</p><p><img src=\"https://static.tigerbbs.com/a45e0699fa17a3da9ad6e88c61dcc813\" tg-width=\"630\" tg-height=\"448\" referrerpolicy=\"no-referrer\"/></p><p><b>2021年<a href=\"https://laohu8.com/S/AAPL\">苹果</a>手机占全球智能手机出货量22% 位居第一</b></p><p>数据研究机构Canalys发布的最新报告显示，得益于iPhone 13的成功，苹果手机在2021年占全球智能手机出货量的22%，坐上全球智能手机市场的头把交椅，<a href=\"https://laohu8.com/S/SMSN.UK\">三星</a>以20%的市场份额紧随其后。此外，小米以12%排名第三，OPPO以9%排名第四，vivo以8%排名前五。</p><p>报告显示，截至2021年底，苹果手机占全球智能手机出货量的22%。Canalys指出，苹果上一次在智能手机市场排名第一是在2020年第四季度。</p><p>Canalys分析师Sanyam Chaurasia在一份声明中表示：“苹果iPhone新旗舰机在中国市场表现十分强劲。”“苹果的供应链开始复苏，但由于关键零部件短缺，苹果在第四季度仍被迫减产，无法生产足够的iPhone来满足需求。”</p></body></html>","source":"XLCJ","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>外媒头条：一次加息50个基点！市场预期越发激进</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n外媒头条：一次加息50个基点！市场预期越发激进\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-19 05:37 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2022-01-19/doc-ikyamrmz6036284.shtml><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>全球财经媒体昨夜今晨共同关注的头条新闻主要有：1、货币市场预计美联储或一次升息50基点 将是2020年以来最大动作2、微软发起其史上最大规模收购 以近690亿美元收购动视暴雪3、贝莱德CEO：美联储“激进”立场或导致收益率曲线趋平4、原油飙升至2014年以来高点 拜登政府称正继续与产油国合作5、研究显示omicron感染浪潮可能降低疫情未来的严重程度6、2021年苹果手机占全球智能手机出货量22%...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2022-01-19/doc-ikyamrmz6036284.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/02a85629f2a809e4eabd8677140a5f70","relate_stocks":{".IXIC":"NASDAQ Composite","BK4550":"红杉资本持仓",".DJI":"道琼斯","BK4504":"桥水持仓",".SPX":"S&P 500 Index","BK4534":"瑞士信贷持仓","BK4559":"巴菲特持仓"},"source_url":"https://finance.sina.com.cn/stock/usstock/c/2022-01-19/doc-ikyamrmz6036284.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2204841800","content_text":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：1、货币市场预计美联储或一次升息50基点 将是2020年以来最大动作2、微软发起其史上最大规模收购 以近690亿美元收购动视暴雪3、贝莱德CEO：美联储“激进”立场或导致收益率曲线趋平4、原油飙升至2014年以来高点 拜登政府称正继续与产油国合作5、研究显示omicron感染浪潮可能降低疫情未来的严重程度6、2021年苹果手机占全球智能手机出货量22% 位居第一货币市场预计美联储或一次升息50基点 将是2020年以来最大动作货币市场价格显示，越来越多投资者预期美联储可能逾二十年来首次大规模提高借贷成本。虽然加息25个基点仍是最有可能的情形，但掉期市场现在预计3月底前加息幅度将超过25个基点。鉴于本月政策会议预计不会有任何行动，这表明交易员至少正在考虑3月加息50个基点的可能性。自2000年5月以来， 美联储还从没有一口气加息这么多过。近日来围绕美联储更大幅加息的猜测升温可能加剧了周二美国国债跌势。 摩根大通首席执行官杰米·戴蒙上周警告美联储收紧政策可能不会像一些人预期的那样“和风细雨”，亿万富翁投资者Bill Ackman表示美联储应该在3月加息50个基点，以重建公信力。CFTC最新持仓数据显示，对冲基金将净欧洲美元空头头寸提高至2018年12月以来最大水平，投机者对10年期国债期货的看空程度也达到2020年2月以来最高。微软发起其史上最大规模收购 以近690亿美元收购动视暴雪微软宣布以687亿美元收购动视暴雪，促成视频游戏领域的两大巨头强强联合。作为微软有史以来进行的最大一笔收购，该交易对这家美国最大游戏发行商之一的收购价为每股95美元现金。微软称，动视暴雪首席执行官Bobby Kotick将继续担任当前职位。交易完成后，动视暴雪业务将汇报给微软游戏部门负责人Phil Spencer。交易完成后，微软将成为按营收计算的全球第三大游戏公司，仅次于腾讯和索尼。将动视暴雪热门游戏收入囊中，将有助于微软扩大其Xbox游戏机内容，提高对索尼PlayStation的竞争力。动视暴雪与Xbox的合作由来已久。这家发行商最大一款游戏《使命召唤》的成功，很大程度上是得益于微软创新性的在线平台Xbox Live，该平台允许玩家联机进行多人对战。动视暴雪大多数游戏都在Xbox游戏机上发布。贝莱德CEO：美联储“激进”立场或导致收益率曲线趋平全球最大资产管理公司贝莱德CEO Larry Fink表示，美联储快速调整货币政策以遏制通胀可能会导致美国国债收益率曲线趋于平缓。“我认为收益率曲线将会变平，如果美联储非常激进，我甚至可以看到一条负的收益率曲线，”Fink周二表示。收益率曲线的形状揭示了投资者对美国经济增长和货币政策的预期。美联储计划早于预期加息的鹰派立场推高了短期利率，使曲线变平。分析师通常认为，短期美国国债收益率与较长期美债收益率之差缩小（即收益率曲线趋平），是对经济增长和货币政策不确定性的担忧迹象。负的收益率曲线或曲线倒挂通常预示着经济衰退。“收益率曲线的形状将成为决定经济的关键问题，”Fink说。原油飙升至2014年以来高点 拜登政府称正继续与产油国合作油价升至七年高点之际，白宫称拜登政府正在与产油国合作，将确保供应达到足以满足需求的水平。美国国家安全委员会发言人Emily Horne周二在一份声明中表示，白宫计划继续在全球经济增长的背景下监控能源价格，必要时会与OPEC+国家举行磋商。Horne称，“我们会继续与产油国和消费国合作，这些措施已经对价格产生了实际影响，我们仍然保留可解决能源价格问题的工具” 。汽油价格上涨一直是导致拜登任期内通胀飙升的主要因素，白宫千方百计降低汽油成本。油价上涨正在损害拜登的支持率，民主党在11月中期选举中保住两院多数党地位的难度加大。研究显示omicron感染浪潮可能降低疫情未来的严重程度南非的研究人员表示，虽然omicron变种病毒引发一轮强烈的新冠疫情浪潮，但却可能会加速大流行病所造成各种干扰的终结，因为感染omicron的症状似乎较轻，并能提供针对德尔塔变种病毒的保护。南非一个实验室将去年11月和12月感染omicron的23人作为样本进行的研究显示，虽然先前感染了德尔塔毒株的人可以感染omicron，但感染omicron株的人不会再感染德尔塔。尽管omicron的感染力明显高于德尔塔，但包括南非在内的一些国家的医院和死亡率数据似乎表明，它导致的疾病严重程度较低。南非是最早出现omicron感染浪潮的国家。南非卫生研究所Alex Sigal等人的这项研究显示，omicron可以取代德尔塔毒株。“这种取代的影响将取决于omicron的致病性是否确实低于德尔塔，”研究人员说。 “如果的确如此，那么Covid-19重症的发生率将降低，疫情对个人和社会的破坏性将会减弱。”2021年苹果手机占全球智能手机出货量22% 位居第一数据研究机构Canalys发布的最新报告显示，得益于iPhone 13的成功，苹果手机在2021年占全球智能手机出货量的22%，坐上全球智能手机市场的头把交椅，三星以20%的市场份额紧随其后。此外，小米以12%排名第三，OPPO以9%排名第四，vivo以8%排名前五。报告显示，截至2021年底，苹果手机占全球智能手机出货量的22%。Canalys指出，苹果上一次在智能手机市场排名第一是在2020年第四季度。Canalys分析师Sanyam Chaurasia在一份声明中表示：“苹果iPhone新旗舰机在中国市场表现十分强劲。”“苹果的供应链开始复苏，但由于关键零部件短缺，苹果在第四季度仍被迫减产，无法生产足够的iPhone来满足需求。”","news_type":1},"isVote":1,"tweetType":1,"viewCount":1822,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696638036,"gmtCreate":1640677949442,"gmtModify":1640677949520,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"Ok,goood","listText":"Ok,goood","text":"Ok,goood","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696638036","isVote":1,"tweetType":1,"viewCount":1402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696076550,"gmtCreate":1640587154486,"gmtModify":1640587154568,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"Ok, great idea","listText":"Ok, great idea","text":"Ok, great idea","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696076550","isVote":1,"tweetType":1,"viewCount":973,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698712448,"gmtCreate":1640541251767,"gmtModify":1640541251767,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"Okokok☺️☺️☺️","listText":"Okokok☺️☺️☺️","text":"Okokok☺️☺️☺️","images":[{"img":"https://static.tigerbbs.com/a253a16a74a2b4e30af15fc0fad7fd1b","width":"1599","height":"899"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698712448","isVote":1,"tweetType":1,"viewCount":1264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":607924086,"gmtCreate":1639477703329,"gmtModify":1639477703448,"author":{"id":"3582126034262927","authorId":"3582126034262927","name":"TAN PS","avatar":"https://static.tigerbbs.com/5a0d84dc68e395bfc24b888753e86fdb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582126034262927","idStr":"3582126034262927"},"themes":[],"htmlText":"🤔🤔🤔","listText":"🤔🤔🤔","text":"🤔🤔🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607924086","repostId":"1173824820","repostType":4,"repost":{"id":"1173824820","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639406936,"share":"https://www.laohu8.com/m/news/1173824820?lang=&edition=full","pubTime":"2021-12-13 22:48","market":"us","language":"en","title":"Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1173824820","media":"Tiger Newspress","summary":"Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion.On Decem","content":"<p>Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion.<img src=\"https://static.tigerbbs.com/2541d11930fa271c03180dbe4f2b3f76\" tg-width=\"776\" tg-height=\"557\" width=\"100%\" height=\"auto\">On December 9th, EST, Nubank, a Latin American digital banking giant, landed on the New York Stock Exchange, with an issue price of US $9 and a surge of 36% at the opening. According to the market value of US $47.6 billion after hours, Nubank is already the largest listed bank in Latin America.</p>\n<p>The company said it had a $99 million loss on revenue of $1.06 billion for the nine-month period ended Sept. 30. Interest income accounted for $607 million of that revenue, with fees and commissions making up the remainder.</p>\n<p>Nubank warned investors to brace for “short-term profit implications” from the firm’s expansion push.</p>\n<p>Chief Executive Officer David Velez will own a stake in the company worth about $8.9 billion at the IPO price. His co-founder, Cristina Junqueira, has a stake worth $1.1 billion.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNu Holdings slid over 8% in morning trading,with its market value falling below $50 billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 22:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion.<img src=\"https://static.tigerbbs.com/2541d11930fa271c03180dbe4f2b3f76\" tg-width=\"776\" tg-height=\"557\" width=\"100%\" height=\"auto\">On December 9th, EST, Nubank, a Latin American digital banking giant, landed on the New York Stock Exchange, with an issue price of US $9 and a surge of 36% at the opening. According to the market value of US $47.6 billion after hours, Nubank is already the largest listed bank in Latin America.</p>\n<p>The company said it had a $99 million loss on revenue of $1.06 billion for the nine-month period ended Sept. 30. Interest income accounted for $607 million of that revenue, with fees and commissions making up the remainder.</p>\n<p>Nubank warned investors to brace for “short-term profit implications” from the firm’s expansion push.</p>\n<p>Chief Executive Officer David Velez will own a stake in the company worth about $8.9 billion at the IPO price. His co-founder, Cristina Junqueira, has a stake worth $1.1 billion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NU":"Nu Holdings Ltd."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173824820","content_text":"Nu Holdings slid over 8% in morning trading,with its market value falling below $50 billion.On December 9th, EST, Nubank, a Latin American digital banking giant, landed on the New York Stock Exchange, with an issue price of US $9 and a surge of 36% at the opening. According to the market value of US $47.6 billion after hours, Nubank is already the largest listed bank in Latin America.\nThe company said it had a $99 million loss on revenue of $1.06 billion for the nine-month period ended Sept. 30. Interest income accounted for $607 million of that revenue, with fees and commissions making up the remainder.\nNubank warned investors to brace for “short-term profit implications” from the firm’s expansion push.\nChief Executive Officer David Velez will own a stake in the company worth about $8.9 billion at the IPO price. His co-founder, Cristina Junqueira, has a stake worth $1.1 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":567,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}